Driven Deliveries (DRVD) 10-Q 30 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Jun. 24, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Driven Deliveries, Inc.
Entity Central Index Key	0001629606
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	DE
Entity File Number	333-209836
Entity Common Stock, Shares Outstanding		67,523,835

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash	$ 364,121	$ 266,869
Accounts receivable	70,903	127,747
Receivable from merchant processor	206,734	206,734
Due from affiliate		346,610
Other current asset	3,767
Inventory	717,656	149,946
TOTAL CURRENT ASSETS	1,363,181	1,097,906
Intangible assets, net	12,775,350	4,622,267
Excess purchase price over net liabilities acquired	1,660,999	1,271,718
Right of use asset	657,549	115,859
Fixed assets, net	67,850	81,839
Deposit	91,213	61,138
TOTAL ASSETS	16,616,142	7,250,727
CURRENT LIABILITIES
Accounts payable and accrued expenses	4,124,237	1,700,653
Accrued taxes	782,874	784,168
Settlement payable	311,363	352,272
Notes payable, net of debt discount of $445,139 and $480,108	2,191,860	1,016,892
Notes payable - related party, net of debt discount of $97,753 and $234,667	139,914
Lease liability	295,639	40,217
Derivative liability	558,160	306,762
Acquisition liability	2,202,695	908,469
TOTAL CURRENT LIABILITIES	10,606,742	5,109,433
Lease liability - long term	362,532	76,264
Acquisition liability - long term	442,617	442,617
TOTAL LIABILITIES	11,411,891	5,628,314
COMMITMENTS AND CONTINGENCIES - Note 8
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value, 15,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.0001 par value, 200,000,000 shares authorized, 53,635,054 and 40,961,054 shares issued and outstanding	5,364	4,096
Additional paid in capital	24,017,404	17,387,684
Accumulated deficit	(18,818,517)	(15,241,762)
TOTAL STOCKHOLDERS' EQUITY	5,204,251	2,150,018
NON-CONTROLLING INTEREST		(527,605)
TOTAL STOCKHOLDERS' EQUITY	5,204,251	1,622,413
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 16,616,142	$ 7,250,727

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	15,000,000	15,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	53,635,054	40,961,054
Common stock, shares outstanding	53,635,054	40,961,054
Net of debt discount	$ 445,139	$ 480,108
Related party net of debt discount	$ 97,753	$ 234,667

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
REVENUE
Sales	$ 2,195,448	$ (19,417)
Cost of goods sold	1,704,387
Gross Profit (Loss)	491,061	(19,417)
OPERATING EXPENSES
Professional fees	450,615	167,757
Compensation	1,359,004	537,183
General and administrative expenses	1,086,493	178,864
Sales and marketing	180,753	40,774
Total Operating Expenses	3,076,865	924,578
NET LOSS FROM OPERATIONS	(2,585,804)	(943,995)
OTHER EXPENSES
Interest expense	(262,892)	(10,167)
Loss on sale of fixed asset	(11,970)
Change in fair value of derivative liability	(34,155)
Loss on extinguishment of debt	(810,518)	(225)
Total Other Expenses	(1,119,535)	(10,392)
Net loss before provision for income taxes	(3,705,339)	(954,387)
Provision for Income Taxes
NET LOSS	(3,705,339)	(954,387)
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST	(128,584)
NET LOSS ATTRIBUTABLE TO DRIVEN DELIVERIES, INC. & SUBSIDIARY	$ (3,576,755)	$ (954,387)
Net loss per share - basic and diluted	$ (0.08)	$ (0.02)
Weighted average number of shares outstanding during the period - basic and diluted	45,726,329	44,290,295

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholder’s Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Non-controlling Interest	Stock Subscription Receivable	Total
Beginning balance at Dec. 31, 2018	$ 4,088	$ 2,425,275	$ (2,681,192)		$ (100,000)	$ (351,829)
Beginning balance, Shares at Dec. 31, 2018	40,875,014
Sale of common stock	$ 506	1,011,494				1,012,000
Sale of common stock, Shares	5,060,000
Issuance of options for services		244,062				244,062
Issuance of options for services, Shares
Issuance of warrants for services		103,632				103,632
Issuance of warrants for services, Shares
Issuance of common stock and warrants for cancellation of debt	$ 37	53,823				53,860
Issuance of common stock and warrants for cancellation of debt, Shares	375,000
Proceeds from stock subscription receivable					100,000	100,000
Net loss			(954,387)			(954,387)
Ending balance at Mar. 31, 2019	$ 4,631	3,838,286	(3,635,579)			207,338
Ending balance, Shares at Mar. 31, 2019	46,310,014
Beginning balance at Dec. 31, 2019	$ 4,096	17,387,684	(15,241,762)	(527,605)		1,622,413
Beginning balance, Shares at Dec. 31, 2019	40,961,054
Sale of common stock	$ 68	336,932				337,000
Sale of common stock, Shares	674,000
Issuance of options for services		121,539				121,539
Issuance of options for services, Shares
Issuance of warrants for services		206,265				206,265
Issuance of warrants for services, Shares
Warrants issued with notes		622,373				622,373
Warrants issued with notes, Shares
Issuances of common stock for merger	$ 1,200	5,998,800				6,000,000
Issuances of common stock for merger, Shares	12,000,000
Reclassification of non-controlling interest for merger		(656,189)		656,189
Net loss			(3,576,755)	(128,584)		(3,705,339)
Ending balance at Mar. 31, 2020	$ 5,364	$ 24,017,404	$ (18,818,517)			$ 5,204,251
Ending balance, Shares at Mar. 31, 2020	53,635,054

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,705,339)	$ (954,387)
Adjustments to reconcile net loss to net cash used in operating activities
Loss on extinguishment of debt	810,518	225
Stock based compensation	327,804	347,694
Amortization of right-of-use asset	(3,767)	4,199
Amortization of debt discount	200,980
Depreciation and amortization expense	345,138	2,748
Change in fair value of derivative liability	34,155
Loss on sale of fixed asset	11,970
Changes in operating assets and liabilities
Inventory	(435,260)
Settlement payable	(40,909)
Deposit	(1,575)
Accounts payable and accrued compensation	1,000,309	(73,902)
Accrued taxes	(1,294)
Accounts receivable	56,844
Other current asset		(13,829)
Net Cash Used In Operating Activities	(1,400,426)	(687,252)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash acquired in acquisition	20,678
Purchase of fixed assets		(29,346)
Net Cash Provided by (Used In) Investing Activities	20,678	(29,346)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from stock receivable		100,000
Proceeds from loan payable	1,140,000
Repayments of loan payable		(50,000)
Proceeds from loan payable - related party		23,726
Repayments of loan payable - related party		(8,705)
Common stock issued for cash	337,000	1,012,000
Net Cash Provided By Financing Activities	1,477,000	1,077,021
NET INCREASE IN CASH	97,252	360,423
CASH AT BEGINNING OF PERIOD	266,869	5,249
CASH AT END OF PERIOD	364,121	365,672
NON-CASH INVESTING AND FINANCING ACTIVITIES
Warrants and consideration - business combination	8,261,098
Issuance of common stock and warrants for cancellation of debt		53,860
Lease liability recognized from right of use asset	582,065	250,040
Settlement of related party AP for related party debt	$ 30,000

Organization and Nature of Busi

Organization and Nature of Business	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND NATURE OF BUSINESS	NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS Overview Driven Deliveries Inc. (formerly Results-Based Outsourcing Inc) (the "Company" or "Driven"), formed on July 22, 2013, is engaged in selling legal cannabis products to consumers in California. On August 29, 2018, Driven Deliveries, Inc., a Nevada company ("Driven Nevada"), was acquired by Results-Based Outsourcing Inc. as part of a reverse merger transaction. As consideration for the merger, Results-Based Outsourcing Inc. issued the equity holders of Driven Nevada an aggregate of 30,000,000 post-split shares of their common stock. Following the merger, the Company adopted the business plan of Driven Nevada as a delivery company focused on deliveries for consumers of legal cannabis products, in California. The merger was accounted for as a recapitalization of the Company, therefore the financial statements as presented in this report include the historical results of Driven Nevada. In June 2019, the Company completed its acquisition of Ganjarunner, Inc. and Global Wellness, LLC, which are engaged in the business of selling legal cannabis products to consumers in California. See Note 4 – Merger and Asset Purchase Agreement below for more information on the acquisition. In July 2019, the Company entered into an Asset Purchase Agreement with Mountain High Recreation, Inc., in which the Company acquired certain limited assets from Mountain High Recreation, Inc. See Note 4 – Merger and Asset Purchase Agreement for more information on the asset purchase. In September 2019 the Company entered into a Joint Venture agreement with Budee, Inc. to expand our operations and engaged in the business of providing delivery services of legal cannabis products to the consumer in California. See Note 5 – Joint Venture for more information on the Joint Venture. On February 27, 2020, the Company entered into an Agreement and Plan of Merger by and among the Company, Budee Acquisition, Inc., a Nevada corporation and Budee, Inc., a California corporation, pursuant to which the Company acquired Budee. See Note 4 – Merger and Asset Purchase Agreement for more information on the acquisition. Risks and Uncertainties The Company's business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal governmental policy decisions. A host of factors beyond the Company's control could cause fluctuations in these conditions. Adverse conditions may include: changes in the cannabis regulatory environment and competition from larger more well-funded companies. These adverse conditions could affect the Company's financial condition and the results of its operations. In December 2019, a novel strain of coronavirus, COVID-19, surfaced in Wuhan, China. This virus continues to spread around the world, resulting in business and social disruption. The coronavirus was declared a Public Health Emergency of International Concern by the World Health Organization on January 30, 2020. The operations and business results of the Company could be materially adversely affected as a result of the pandemic. Employers are also required to prepare for and increase, by as much capacity as possible, the arrangement for employees to work remotely. The extent to which the coronavirus may impact business activity or results of operations will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions required to contain the coronavirus or treat its impact, among others.

Going Concern Analysis

Going Concern Analysis	3 Months Ended
	Mar. 31, 2020
Going Concern Analysis [Abstract]
GOING CONCERN ANALYSIS	NOTE 2 – GOING CONCERN ANALYSIS Going Concern Analysis The accompanying consolidated condensed financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. For the three months ended March 31, 2020, the Company had a net loss of $3,705,339 and working capital deficit of $9,243,561. The Company will require additional capital in order to continue its operations in the normal course of business. Management has concluded that due to these conditions, there is substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated condensed financial statements have been prepared assuming that the Company will continue as a going concern for one year from the issuance of these financial statements. Management's plans include raising capital through the sale of debt and/or equity. The Company's ability to continue as a going concern is dependent upon its ability to raise capital to implement the business plan, generate sufficient revenues and to control operating expenses. While we believe in the viability of our strategy to generate sufficient revenue, control costs and the ability to raise additional funds, there can be no assurances that our strategy will be successful. The Company's financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the matters discussed herein.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial information. In the opinion of the Company's management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal, recurring adjustments, considered necessary for a fair presentation of the results for the interim period ended March 31, 2020. Although management believes that the disclosures in these unaudited condensed consolidated financial statements are adequate to make the information presented not misleading, certain information and footnote disclosures normally included in financial statements that have been prepared in accordance U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company's financial statements for the year ended December 31, 2019, which contains the audited financial statements and notes thereto, for the year ended December 31, 2019 included within the Company's Form 10-K filed with the SEC on May 22, 2020. The interim results for the three months ended March 31, 2020 are not necessarily indicative of the results to be expected for the year ended December 31, 2020 or for any future interim periods. The December 31, 2019 Balance Sheet is derived from the Company's audited financial statements but does not include all necessary disclosures for full U.S. GAAP presentation. Principles of consolidation The consolidated condensed financial statements include the accounts of Driven Deliveries, Inc., and its wholly-owned subsidiaries, Budee, Inc., Ganjarunner, Inc. and Global Wellness, LLC. All significant intercompany balances and transactions have been eliminated in the consolidated condensed financial statements. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Risk factors In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 ("2017 Tax Act"). Corporate taxpayers may carryback net operating losses (NOLs) originating between 2018 and 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act. In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation. Concentrations The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may have deposits in excess of federally insured limits. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2020 and December 31, 2019, the Company did not have any cash equivalents. Inventory Inventory consists of finished goods and is stated at the lower of cost or net realizable value, on an average cost basis. Inventory is determined to be salable based on demand forecast within a specific time horizon. Inventory in excess of salable amounts is considered obsolete, at which point it is written down to its net realizable value. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The Company does not record an allowance for doubtful accounts. Goodwill We review goodwill for impairment at least annually or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. As of March 31, 2020, no impairment of goodwill has been identified. Goodwill Balance, January 1, 2019 $ - Additions 1,271,718 Balance, December 31, 2019 1,271,718 Additions 389,281 Balance, March 31, 2020 $ 1,660,999 Intangible Assets The Company's intangible assets include the following at March 31, 2020: Cost Basis Accumulated Net at Estimated Trade Names/Trademarks $ 4,440,962 $ (165,967 ) $ 4,274,995       10 IP/Trade Secrets 3,053,060 (313,686 ) 2,739,374 5 License 1,064,684 (51,193 ) 1,013,491 15 Proprietary Software/Technology 4,189,000 (54,105 ) 4,134,895 7 Non-Compete Agreements 536,009 (116,935 ) 419,074 2 Customer Relations 211,000 (17,479 ) 193,521 7 Total Intangible Assets $ 13,494,715 (719,365 ) $ 12,775,350 The Company's intangible assets include the following at December 31, 2019: Cost Basis Accumulated Net at Estimated Life Trade Names/Trademarks $ 1,918,962 $ (95,324 ) $ 1,823,638       10 IP/Trade Secrets 1,978,060 (195,616 ) 1,782,444 5 License 678,684 (22,463 ) 656,221 15 Proprietary Software/Technology 289,009 (69,742 ) 219,267 7 Customer Relations 152,000 (11,303 ) 140,697 7 Total Intangible Assets $ 5,016,715 $ (394,448 ) $ 4,622,267 There was no impairment recorded to intangible assets as of March 31, 2020. Amortization expense was $341,583 and $280,616 for the three months ended March 31, 2020 and December 31, 2019, respectively. The future amortization expense intangible assets are as follows: 2020 (remainder) $ 1,251,254 2021 2,119,392 2022 1,814,416 2023 1,728,525 2024 1,535,478 2025 and after 4,326,285 Total $ 12,775,350 Cost of Sales Cost of goods sold consists of: Product costs: Product costs include the purchase price of products sold, which include direct and indirect labor costs, rent, and depreciation expenses, and inbound shipping and handling costs for inventory. Fulfillment costs and other: includes the costs of outbound shipping and handling and other costs related to delivering products to the customer. The Company's cost of sales for March 31, 2020 and 2019 are as follows: Cost of Sales Type Three months Three months Cost of Sales – Product Costs $ 1,111,539 - Cost of Sales – Fulfilment Costs and Other 592,848 - Total $ 1,704,387 - Advertising The Company expenses the cost of advertising and promotions as incurred. Advertising expense was $180,080 and $40,774 for the three months ended March 31, 2020 and 2019, respectively. Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of ASC 718, "Compensation–Stock Compensation", which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or cancelled during the periods reported. The Company accounts for warrants and options issued to non-employees under ASU 2018-07, Equity – Equity Based Payments to Non-Employees, using the Black-Scholes option-pricing model. The Black–Scholes option valuation model requires the development of assumptions that are inputs into the model. These assumptions are the value of the underlying share, the expected stock volatility, the risk–free interest rate, the expected life of the option, the dividend yield on the underlying stock and are accounted for as they occur. Due to the lack of sufficient trading history, the Company benchmarked their volatility to similar companies in a similar industry over the expected option life and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on its Common stock and does not intend to pay dividends on its Common stock in the foreseeable future. The Company records forfeitures as they occur. The Company stock based compensation expense was $327,804 and $347,694 for the three months ended March 31, 2020 and 2019, respectively. Fair Value Measurements ASC 820, "Fair Value Measurements and Disclosure," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels are described below: Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company; Level 2 Inputs – Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; Level 3 Inputs – Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants. The carrying amount of the Company's financial assets and liabilities, such as cash, accounts payable, accounts receivables, and accrued expenses approximate their fair value because of the short maturity of those instruments. Non- recurring fair value items are re-assessed at the end of each reporting period. The assets or liability's fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of financial instruments that are measured at fair value as of March 31, 2020. Carrying Fair Value Measurement Using Value Level 1 Level 2 Level 3 Total Derivative liabilities $ (558,160 ) $ - $ - $ (558,160 ) $ (558,160 ) The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2019. Carrying Fair Value Measurement Using Value Level 1 Level 2 Level 3 Total Derivative liabilities $ (306,762 ) $ - $ - $ (306,762 ) $ (306,762 ) The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2020: Fair Value Measurement Using Level 3 Inputs Total Balance, January 1, 2019 $ - Debt Discount 305,424 Change in fair value of derivative liabilities (1,338 ) Balance, December 31, 2019 306,762 Extinguishment (311,360 ) Debt Discount 528,603 Change in fair value of derivative liabilities 34,155 Balance, March 31, 2020 $ 558,160 The level 3 financial instruments consist of embedded conversion features. The fair value of these embedded conversion features are estimated using a Black Scholes valuation model. The fair value of the derivative features were calculated using a Black-Scholes option model valued with the following assumptions: March 31, 2020 December 31, 2019 Exercise price $ 0.50 $ 0.50 Risk free interest rate 0 .88-1.12 % 1.52-1.81 % Dividend yield 0.00 % 0.00 % Expected volatility 97-119 % 93-109 % Contractual term 0.88-1.19 Years 0.91-1.37 Estimated fair value of stock on grant date $ 0.50 $ 0.50 Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of measurement. Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future. Volatility: The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company's peer group stock price for a period consistent with the warrants' expected term. Expected term: The Company's expected term is based on the remaining contractual maturity of the warrants. Changes in the unobservable input values would likely cause material changes in the fair value of the Company's Level 3 financial instruments. The most sensitive unobserved inputs used in valuing derivative instruments are volatility and estimated fair value of the Company's stock on the grant date of the instruments. Significant changes in either of these inputs could have a material effect on the fair value measurement of the derivative instruments. During the three months ended March 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded a loss of $34,155 and $0 relating to the change in fair value, respectively. Derivative Liability The Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated condensed statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity or to gain or loss on extinguishment of the note if the derivative is attached to a note. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date. The pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time of comparable companies equal to the remaining contractual term of the instrument granted. Revenue Recognition As of January 1, 2018, the Company adopted ASC 606. The adoption of ASC 606, Revenue From Contracts With Customers, represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company's services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. The Company used the Modified-Retrospective Method when adopting this standard. There was no accounting effect due to the initial adoption. To achieve this core principle, the Company applies the following five steps: 1) Identify the contract with a customer The Company sells retail products directly to customers. In these sales there is no formal contract with the customer. These sales have commercial substance and there are no issues with collectability as the customer pays the cost of the goods at the time of purchase or delivery. 2) Identify the performance obligations in the contract The Company sells its products directly to consumers. In this case these sales represent a performance obligation with the sales and any necessary deliveries of those products. 3) Determine the transaction price The sales that are done directly to the customer have no variable consideration or financing component. The transaction price is the cost that those goods are being sold for plus any additional delivery costs. 4) Allocate the transaction price to performance obligations in the contract For the goods that the Company sells directly to customers, the transaction price is allocated between the cost of the goods and any delivery fees that may be incurred to deliver to the customer. 5) Recognize revenue when or as the Company satisfies a performance obligation For the sales of the Company's own goods the performance obligation is complete once the customer has received their product. Disaggregation of Revenue The following table depicts the disaggregation of revenue according to revenue type. Revenue Type Revenue for the three months ended March 31, 2020 Revenue for the three months ended March 31, 2019 Delivery Income $ 27,043 15,370 Dispensary Cost Reimbursements (7,528 ) (34,787 ) Delivery Income, net 19,515 (19,417 ) Product Sales 2,175,933 - Total $ 2,195,448 (19,417 ) As part of the Company's former delivery business where the Company partnered with dispensaries to deliver their products, the Company was responsible for reimbursing the partnered dispensaries for the wages of the delivery couriers. Due to this reduction of revenue from the reimbursement of wages for the delivery couriers, the Company is presenting a net negative revenue for the three months ended March 31, 2019 for Dispensary Delivery Income. Leases Under Topic 842, operating lease expense is generally recognized evenly over the term of the lease. The Company has operating leases primarily consisting of office space with remaining lease terms of 35 months to 37 months. Current facility leases include our offices in El Segundo California, Oakland California, and Sacramento California. Lease costs were $40,375 and $44,060 for the three months ended March 31, 2020 and 2019. There was no sublease rental income for the three months ended March 31, 2020 and 2019. Leases with an initial term of twelve months or less are not recorded on the balance sheet. For lease agreements entered into or reassessed after the adoption of Topic 842, we combine the lease and non-lease components in determining the lease liabilities and right of use ("ROU") assets. Our lease agreements generally do not provide an implicit borrowing rate, therefore an internal incremental borrowing rate is determined based on information available at lease commencement date for purposes of determining the present value of lease payments. We used the incremental borrowing rate on March 31, 2020 and December 31, 2019 for all leases that commenced prior to that date. In determining this rate, which is used to determine the present value of future lease payments, we estimate the rate of interest we would pay on a collateralized basis, with similar payment terms as the lease and in a similar economic environment. Lease Costs Three Months Ended Three Months Ended Components of total lease costs: Operating lease expense $ 40,375 $ 44,060 Total lease costs $ 40,375 $ 44,060 Lease Positions as of March 31, 2020 ROU lease assets and lease liabilities for our operating leases were recorded in the consolidated condensed balance sheet as follows: March 31, December 31, 2019 Assets Right of use asset $ 657,549 $ 115,859 Total assets $ 657,549 $ 115,859 Liabilities Operating lease liabilities – short term $ 295,639 $ 40,217 Operating lease liabilities – long term 362,532 76,264 Total lease liability $ 658,171 $ 116,481 Lease Terms and Discount Rate Weighted average remaining lease term (in years) – operating lease 3.58 Weighted average discount rate – operating lease 10.91 % Cash Flows Three Months Ended Three Months Ended Cash paid for amounts included in the measurement of lease liabilities: ROU amortization $ 40,375 $ 11,274 Cash paydowns of operating liability $ (40,375 ) $ (7,075 ) Supplemental non-cash amounts of lease liabilities arising from obtaining ROU asset $ (657,549 ) $ (261,969 ) Lease Liability $ 658,171 $ 266,869 The future minimum lease payments under the leases are as follows: 2020 (remainder) $ 217,557 2021 250,543 2022 231,678 2023 39,178 Total future minimum lease payments 738,956 Less: Lease imputed interest 80,785 Total $ 658,171 Excise and Sales Tax The State of California and various local governments impose certain excise and state and local taxes on product sales. The Company's policy is to include excise taxes as part of sales and cost of sales. The Company's policy for various state and local sales taxes are to exclude them from revenue and cost of sales. Basic and Diluted Net Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding for each period. For diluted earnings per common share, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As of March 31, 2020, common stock equivalents are comprised of 34,578,750 warrants and 7,992,433 options. Recent Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350)—Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the accounting for goodwill impairments by eliminating the requirement to compare the implied fair value of goodwill with its carrying amount as part of step two of the goodwill impairment test referenced in Accounting Standards Codification ("ASC") 350, Intangibles - Goodwill and Other ("ASC 350"). As a result, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit's fair value. However, the impairment loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. ASU 2017-04 is effective for annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material impact on the Company's consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement" ("ASU 2018-13"). ASU 2018-13 removes, modifies and adds certain disclosure requirements in Topic 820 "Fair Value Measurement". ASU 2018-13 eliminates certain disclosures related to transfers and the valuations process, modifies disclosures for investments that are valued based on net asset value, clarifies the measurement uncertainty disclosure, and requires additional disclosures for Level 3 fair value measurements. ASU 2018-13 is effective for the Company for annual and interim reporting periods beginning January 1, 2020. The adoption of this standard did not have a material impact on the Company's consolidated financial statements and related disclosures. In December 2019, the FASB issued authoritative guidance intended to simplify the accounting for income taxes (ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes"). This guidance eliminates certain exceptions to the general approach to the income tax accounting model and adds new guidance to reduce the complexity in accounting for income taxes. This guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within those annual periods. The Company is currently evaluating the potential impact of this guidance on its consolidated financial statements. In May, 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to US businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provides a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses and the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements. In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815), which clarifies the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. The guidance clarifies how to account for the transition into and out of the equity method of accounting when considering observable transactions under the measurement alternative. The ASU is effective for annual reporting periods beginning after December 15, 2020, including interim reporting periods within those annual periods, with early adoption permitted. We are currently evaluating the impact of the new guidance on our consolidated financial statements. The FASB issues ASUs to amend the authoritative literature in ASC. There have been several ASUs to date, that amend the original text of ASC. Management believes that those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to us or (iv) are not expected to have a significant impact our financial statements.

Merger and Asset Purchase Agree

Merger and Asset Purchase Agreements	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
MERGER AND ASSET PURCHASE AGREEMENTS	NOTE 4 – MERGER AND ASSET PURCHASE AGREEMENT Ganjarunner Merger On June 21, 2019, the Company, GR Acquisition, Inc. ("GRA"), a Nevada corporation, Ganjarunner, Inc. ("Ganjarunner"), a California corporation, and Global Wellness, LLC ("GW"), a California limited liability company, (Ganjarunner and GW are hereafter referred to collectively as "GR/GW") entered into an Agreement and Plan of Merger (the "Merger Agreement"), pursuant to which GR/GW shall merge with and into GRA, with GRA continuing as the surviving entity and wholly-owned subsidiary of the Company (the "Merger"). The Merger closed on June 24, 2019 (the "Closing Date"). Pursuant to the Merger Agreement, the Company agreed to pay to GR/GW $1,000,000, $150,000 of which has already been paid to GR/GW with $300,000 to be paid in two equal tranches of $150,000 whereby each tranche is subject to GRA's achievement of certain milestones. (i) $350,000 at the earlier to occur of the 6-month anniversary of the Closing Date or upon the Company raising additional funding of at least $2,000,000 and (ii) $300,000 at the end of the 24-month anniversary of the Closing Date. In addition, as further consideration, the Company issued to GR/GW's founders 1,000,000 shares of the Company's common stock on the Closing Date and shall make two additional issuances of 2,000,000 shares of common stock on the 12-month and 24-month anniversaries of the Closing Date, with each respective issuance contingent upon GRA's achievement of certain milestones as set forth in the Merger Agreement. On October 4, 2019, the Company amended the Merger Agreement with GR/GW. As part of this amendment, the Company immediately will issue 5,000,000 warrants to purchase shares of the Company's common stock to GR/GW. These warrants have a term of three years and an exercise price of $0.50. These warrants replace the previously agreed upon common stock consideration of 5,000,000 shares and eliminated the contingencies related to achieving certain milestones as set forth in the initial merger agreement. As of March 31, 2020 and December 31, 2019, the Company owed a total of $583,886 and $583,886 on the acquisition, respectively. Following the closing of the transaction, Ganjarunner's financial statements as of the Closing Date are consolidated with the Consolidated Condensed Financial Statements of the Company. The following presents the consideration paid for the acquisition of Ganjarunner and the preliminary purchase price allocation. These amounts are provisional and may be adjusted during the measurement period. Purchase Price Purchase Price $ 2,987,254 Total purchase price $ 2,987,254 Allocation of purchase price Tangible Assets/(Liabilities) $ (459,464 ) Trade Names/Trademarks 877,000 IP/Trade Secrets 801,000 License 306,000 Non-Compete Agreements 39,000 Customer Relationships 152,000 Goodwill (incl. trained and assembled workforce) 1,271,718 Total allocation of purchase price $ 2,987,254 Mountain High Asset Purchase On July 10, 2019 (the "Closing Date"), the Company and Mountain High Recreation, Inc. ("MH"), a California corporation, entered into an Asset Purchase Agreement (the "Purchase Agreement"), pursuant to which the Company acquired certain assets from MH as specified in the Purchase Agreement, which included (i) the option to purchase to MH's California Cannabis - Retailer Nonstorefront License (ii) the option to purchase a certain real property lease located at 8 Light Sky Ct, Sacramento, CA 95828 associated with that certain license, (iii) the right to use all trademarks and intellectual property associated with the MH brand (the "Assets"). The Company assumed no liabilities of MH. The transactions contemplated by the Purchase Agreement closed on July 10, 2019 (the "Closing"). Pursuant to the Agreement, the Company agreed to pay to MH the following: $200,000 at Closing, $150,000 on or before December 20, 2019, $150,000 on or before March 31, 2020, $250,000 at the end of the twelfth (12th) month (on a rolling basis) following the Closing Date and $250,000 at the end of the twenty-fourth (24th) month (on a rolling basis) following the Closing Date. In addition, at Closing, the Company issued to MH 1,000,000 shares of its common stock. At the end of the twelfth month (on a rolling basis) from the Closing Date, the Company agreed to issue to MH warrants to purchase 2,000,000 shares of the Company's Common Stock with an exercise price equal to the per share purchase price paid by investors of the Company's then most recent private placement and exercisable for a period of three (3) years from the date of issuance (the "2020 Warrants"). At the end of the twenty-fourth month (on a rolling basis) from the Closing Date, the Company shall issue to MH warrants to purchase 2,000,000 shares of the Company's Common Stock with an exercise price equal to the per share purchase price paid by investors of the Company's then most recent private placement price, exercisable for a period of three (3) years from the date of issuance (the "2021 Warrants"). The 2020 Warrants and 2021 Warrants are subject to adjustment, based on the amount of gross revenue the Company recognized in connection with the Assets. On October 4, 2019, the Company amended the Asset Purchase Agreement with Mountain High Recreation, Inc. As part of this amendment, the Company issued 5,000,000 warrants to purchase shares of the Company's common stock to Mountain High Recreation, Inc. These warrants have a term of three years and an exercise price of $0.50. These warrants replace the previously agreed upon share and warrant consideration and eliminated the contingencies related to the gross revenue recognized in connection with the assets. As of March 31, 2020 and December 31, 2019, the Company owed a total of $708,347 and $708,347 on the acquisition, respectively. The following presents the consideration paid for the asset acquisition of Mountain High Recreation, Inc. and the preliminary purchase price allocation. These amounts are provisional and may be adjusted during the measurement period. Purchase Price Purchase Price $ 2,841,715 Total purchase price $ 2,841,715 Allocation of purchase price Trade Names / Trademarks $ 1,041,962 IP/Trade Secrets 1,177,060 License 372,684 Non-Compete Agreements 250,009 Total allocation of purchase price $ 2,841,715 Budee Merger On February 27, 2020 (the "Effective Date"), Driven Deliveries, Inc. (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among the Company, Budee Acquisition, Inc., a Nevada corporation and Budee, Inc. ("Budee"), a California corporation, pursuant to which the Company acquired Budee (the "Budee Acquisition"). On the Effective Date, all then-issued and outstanding shares of Budee were canceled and Budee issued 1,000,000 new shares of its common stock, representing 100% of the now issued and outstanding shares of Budee, to the Company. As a result, Budee became a wholly-owned subsidiary of the Company. As consideration, the Company agreed to: i) cash payments to Budee of $725,000 in three payments of $225,000, $200,000 and $300,000, due April 15, 2020, July 15, 2020 and October 15, 2020, respectively, and ii) issue to Budee 13,333,333 shares of the Company's common stock (the "Consideration Shares"). 1,333,333 of the 13,333,333 shares will not be issued until the completion of a lawsuit. Pursuant to the Merger Agreement, holders of the Consideration Shares received the right to have their Consideration Shares registered with the Securities and Exchange Commission if and when the Company files a new registration statement on Form S-1. As of March 31, 2020 and December 31, 2019, the Company owed a total of $1,294,226 and $0 on the acquisition, respectively. The following presents the consideration paid for the asset acquisition of Budee, Inc. and the preliminary purchase price allocation. These amounts are provisional and may be adjusted during the measurement period. Purchase Price Cash $ 690,504 Stock 6,603,722 Assumed liabilities 1,658,538 Total purchase price $ 8,952,764 Allocation of purchase price Tangible Assets/(Liabilities) $ 85,483 Trade Names/Trademarks 2,522,000 IP/Trade Secrets 1,075,000 License 386,000 Proprietary Software/Technology 4,189,000 Non-Compete Agreements 247,000 Customer Relationships 59,000 Excess Purcahse Price Over Net Liabilites Acquired 389,281 Total allocation of purchase price $ 8,952,764 The following presents the unaudited pro-forma combined results of operations of the Company with the Ganjarunner and Budee Businesses as if the entities were combined on January 1, 2019. Three Months Three Months March 31, March 31, Gross Revenue $ 2,877,813 2,503,494 Gross Profit $ 1,173,426 1,512,628 Net loss $ (3,558,294 ) (1,255,634 ) Net loss per share, basic and diluted $ (0.08 ) (0.03 ) Weighted average number of shares outstanding 45,726,329 44,290,295 The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results of operations are not intended to present actual results that would have been attained had the acquisitions been completed as of January 1, 2019, or to project potential operating results as of any future date or for any future periods.

Joint Venture

Joint Venture	3 Months Ended
	Mar. 31, 2020
Joint Venture [Abstract]
JOINT VENTURE	NOTE 5 – JOINT VENTURE On September 30, 2019, the Company entered into a joint venture agreement (the "JV Agreement") with Budee, Inc., ("Budee'), a privately-held company involved in the delivery of cannabis-related products in California, pursuant to which the parties formed a joint venture company, GanjaBudee Inc., a Nevada Corporation ("GB"), in anticipation of a merger between the parties (the "GanjaBudee Merger'). GB is a separate and independent entity from either party with its own management team and Board of Directors and is owned 51% by the Company and 49% by Budee. The term of GB will continue until such GanjaBudee Merger is effective or any definitive agreement for such GanjaBudee Merger is terminated but in any case will not be for a period of more than sixty months, subject to a mutual extension agreed to by the parties. In connection with the JV Agreement, the Company and Budee agreed to share certain expenses between the Company and Budee, Inc. The Company is also allowed to charge an additional 10% fee on any of these charged back expenses. The Company charged back expenses to Budee totaling $96,610 during the three months ended March 31, 2020. In addition, pursuant to the JV Agreement the Company agreed to pay certain obligations of Budee Inc. of $250,000. As of March 31, 2020, the Company has not paid this amount. As a result of the merger agreement the Company derecognized a non-controlling interest of $656,189 attributable to the Joint Venture in the Statement of Stockholder's Equity. See Note 4.

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 6 – NOTES PAYABLE On August 28, 2019, the Company issued a senior convertible note ("Note") to M2 Equity Partners ("Holder"), pursuant to which the Holder agreed to advance the Company $1,000,000 in three equal installments, with the final installment advanced on October 30, 2019. The Note matures on August 28, 2020 and is the senior obligation of the Company. The Note's principal balance of $1,000,000 bears interest at a rate of 10% per annum and interest payments are payable on a monthly basis. The funds from this loan were distributed in three parts with $333,333 being issued on August 30, 2019, September 30, 2019 and October 30, 2019. An additional $497,000 was received in excess of the original note as of December 31, 2019. These amounts were subject to the same terms as the original note. An additional $1,140,000 was received in excess of the original note during the first quarter of 2020. The principal of the note was amended on January 31, 2020 to be $2,637,000. This amendment also changed the maturity date of the note to February 14, 2021. As of March 31, 2020, the Company had received $2,637,000 in funds from the note. Pursuant to the Note, the Holder has the right to convert all or part of the Note to shares of common stock of the Company at a price equivalent to a value of $0.50 per share of common stock on an as-converted basis. As additional consideration for entering into the exchange, the Company issued to the Holder a three-year warrant to purchase 4,500,000 shares of the Company's common stock at an exercise price of $0.05. The Company also recognized a derivative liability in connection with the note valued at $567,335 as of December 31, 2019 and $558,160 as of March 31, 2020. The derivative occurred due to anti-dilution provisions contained in the conversion feature of the note. To determine how to account for the modification of the Note, the Company performed a net present value test to compare the old note with the new note discounted at the effective interest rate of the original note. Since the change in the net present value between the two notes exceeded 10% of the value of the original note, the note modification needed to be accounted for as an extinguishment of debt. As part of this the Company recognized a $810,518 loss on the extinguishment of debt for the old note. The loss is due to $1,497,000 from the extinguishment of the note, $311,360 from the extinguishment of the derivative offset by $499,505 from the extinguishment of the debt discount and $2,119,373 from the recognition of the new note. The Company recognized a debt discount on the new note of $528,603 at the date of issuance. The Company recognized $83,464 in amortization on the debt discount during the three months ended March 31, 2020, leaving a remaining debt discount of $445,139 at March 31, 2020. In addition, as an inducement to enter into the Note and to fund each advance thereunder, the Company entered into a security agreement with the Holder executed concurrently with the Note (the "Security Agreement"). Pursuant to the Security Agreement, the Company granted the Holder a first priority security interest in certain assets of the Company (the "Collateral") for the benefit of the Holder to secure the Company's obligations under the Note. The occurrence of any event of default under the Note, as well as the Company's failure to observe or perform its obligations under the Security Agreement and such failure goes uncured for five days after receiving notice, constitutes an event of default under the Security Agreement. If an event of default under the Security Agreement occurs, the Holder is entitled to certain rights, including the right to take possession of the Collateral and the right to operate the business of the Company using the Collateral. The Security Agreement terminates when all payments under the Note have been made in full or upon conversion. Matthew Atkinson, a member of M2 owns approximately 5.98% of the Company's common stock. The Company will also be required to appoint a member of M2 to the Board of Directors of the Company for the duration of the term of the debt. The Company will also make an appointment to the Company's Board of Directors and audit committee. During the year ended December 31, 2019, the Company entered into a loan agreement with the Company's CFO, Brian Hayek. Pursuant to the Loan Agreement, the Company issued Mr. Hayek a Secured Convertible Note in the principal amount of $188,743 with an interest rate of 10%. As of March 31, 2020, the amount due on this loan was $184,667. The note is convertible into shares of the Company's equity securities at a price of $0.50 per share or preferred stock designated by the parties in an amount equivalent to a value of $0.50 per share on an as converted basis. The obligation of the Note is an obligation of the Company other than obligations specifically designated otherwise by the Company. In addition, the Company issued Mr. Hayek warrants to purchase 500,000 shares of the Company's common stock at an exercise price of $0.50 per share which warrants terminate five years after their issuance. As part of this loan the Company recognized the intrinsic value of a beneficial conversion feature resulting in a debt discount of $102,111 as of the date of issuance. The Company had a remaining debt discount of $101,831 at December 31, 2019. The Company recognized $25,458 in amortization on the debt discount during the three months ended March 31, 2020, leaving a remaining debt discount of $76,373 at March 31, 2020. On December 31, 2019, the Company entered into a loan agreement with a Director of the Company, Christian Schenk, pursuant to which Mr. Schenk extended a loan to the Company in the amount of $50,000 with an interest rate of 10%. In connection with this loan, the Company issued Mr. Schenk a secured convertible note. The note is convertible into equity of the Company at a price of $0.50 per share of common stock. The note was funded with the proceeds from the settlement of $30,000 in accounts payable to Truck That, LLC and a check from Truck That, LLC in the amount of $20,000 (see Note 9). In addition, the Company issued Mr. Schenk warrants to purchase 150,000 shares of the Company's common stock at an exercise price of $0.50 per share which warrants terminate five years after their issuance. As part of this loan the Company recognized the intrinsic value of a beneficial conversion feature resulting in a debt discount of $28,585 as of the date of issuance. The Company had a remaining debt discount of $28,507 at December 31, 2019.The Company recognized $7,127 in amortization on the debt discount during the three months ended March 31, 2020, leaving a remaining debt discount of $21,380 at March 31, 2020.

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Mar. 31, 2020
Stockholder Equity [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 7 – STOCKHOLDERS' DEFICIT Common Stock The Company is authorized to issue 200,000,000 shares of common stock, par value $0.0001 per share. During the three months ended March 31, 2020, the Company issued 674,000 shares of common stock for cash of $337,000. 12,000,000 shares were issued relating to the merger with Budee. See Note 4. Preferred Stock The Company is authorized to issue 15,000,000 shares of preferred stock, par value $0.0001 per share. The preferred stock may be issued from time to time in one or more series as the Company's Board may authorize. None of the preferred stock has been designated and none are issued and outstanding as of March 31, 2020 and December 31, 2019. Warrants There were 34,578,570 warrants outstanding as of March 31, 2020. The fair value of each stock warrant granted was estimated using the Black-Scholes valuation model with the assumptions as follows: Exercise price $ 0.05 - $0.50 Expected dividend yield 0 % Risk free interest rate 0.43% - 1.71 % Expected life in years 3-7 Expected volatility 133% - 148 % Estimated fair value of stock on grant date $ 0.50 There were 29,243,750 warrants outstanding as of December 31, 2019. The fair value of each stock warrant granted was estimated using the Black-Scholes valuation model with the assumptions as follows: Exercise price $ 0.10 - $0.50 Expected dividend yield 0 % Risk free interest rate 1.42% - 2.66 % Expected life in years 3-7 Expected volatility 134% - 158 % Estimated fair value of stock on grant date $ 0.50 The Company uses the latest common stock sale price as the fair value of stock on grant date rather than the market value of the stock as the Company believes this is a more accurate valuation of the Company's common stock due to the lack of sufficient volume and trading history on the Company's common stock on the OTC Markets. A summary of warrant issuances are as follows: Number Weighted Average Exercise Weighted Average Remaining Contractual Life Warrants Outstanding January 1, 2019 9,131,250 0.19 3.83 Granted 27,658,000 0.44 4.29 Forfeited (7,545,500 ) 0.34 4.48 Outstanding December 31, 2019 29,243,750 $ 0.39 4.10 Granted 5,335,000 0.12 2.92 Outstanding March 31, 2020 34,578,750 $ 0.35 3.70 Nonvested Warrants Shares Nonvested at January 1, 2019 - Granted 27,658,000 Vested (19,762,500 ) Forfeited (7,545,500 ) Nonvested at December 31, 2019 350,000 Granted 5,335,000 Vested (5,378,750 ) Nonvested at March 31, 2020 306,250 During the first quarter of 2020, the Company issued warrants to purchase an aggregate of 5,335,000 shares of common stock of the Company at an exercise price of $0.05 or $0.50 per share. The warrants may be exercised on a cashless basis and have a term of three, five, or seven years. 375,000 warrants were issued for consulting services, 4,500,000 warrants in connection with notes issued to M2, and 460,000 warrants in connection with stock sold. The Company recognized a stock compensation expense of $206,265 and $103,632 three months ended March 31, 2020 and 2019, related to warrants. Options There were 7,992,433 options outstanding as of March 31, 2020. The fair value of each stock option granted was estimated using the Black-Scholes valuation model with the assumptions as follows: Exercise price $ 0.59 Expected dividend yield 0 % Risk free interest rate 0.77 % Expected life in years 3 Expected volatility 150 % Estimated fair value of stock on grant date $ 0.50 There were 7,879,933 options outstanding as of December 31, 2019. The fair value of each stock option granted was estimated using the Black-Scholes valuation model with the assumptions as follows: Exercise price $ 0.10 - $0.50 Expected dividend yield 0 % Risk free interest rate 1.49% - 2.63 % Expected life in years 7 Expected volatility 153% - 157 % Estimated fair value of stock on grant date $ 0.50 The Company uses the latest common stock sale price as the fair value of stock on grant date rather than the market value of the stock as the Company believes this is a more accurate valuation of the Company's common stock due to the lack of sufficient volume and trading history on the Company's common stock on the OTC Markets. A summary of options issuances are as follows: Number Weighted Average Exercise Weighted Average Remaining Contractual Life Weighted Average Options Outstanding January 1, 2019 4,854,692 0.04 3.00 0.19 Granted 6,210,022 0.16 5.13 0.24 Forfeited (3,184,781 ) 0.19 3.53 0.19 Outstanding December 31, 2019 7,879,933 $ 0.14 4.74 $ 0.24 Granted 112,500 0.59 2.98 0.40 Outstanding March 31, 2020 7,992,433 $ 0.15 4.47 $ 0.24 Nonvested Shares Shares Nonvested at January 1, 2019 3,641,019 Granted 6,210,022 Vested (2,840,194 ) Forfeited (3,184,781 ) Nonvested at December 31, 2019 3,826,066 Granted 112,500 Vested (491730 ) Nonvested at March 31, 2020 3,446,836 During the first quarter of 2020, the Company issued stock options to purchase an aggregate of 112,500 shares of common stock of the Company at an exercise price of $0.59 per share. The options expire in three years from the grant date. The Company recognized a stock compensation expense of $121,538 and $245,344 respectively for the three months ended March 31, 2020 and 2019, related to stock options.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 – COMMITMENTS AND CONTINGENCIES Carla Baumgartner, Chris Haas, and Eric Steele ("Plaintiff") filed a Complaint against Driven Deliveries, Inc. ("Driven"), and Brian Hayek and Christian Schenk, individually, on November 26, 2019 in San Diego County Superior Court, Case No. 37-2019-00063208. In June 2019, Driven entered into a Merger Agreement with Ganjarunner, Inc. ("Ganjarunner"), whereby Driven acquired Ganjarunner. Plaintiffs, the former owners of Ganjarunner, allege in their First Amended Complaint causes of action for Breach of the Merger Agreement, Fraudulent Inducement, Fraudulent Concealment, Negligent Misrepresentation, Breach of Fiduciary Duty, Violation of Corporate Code § 25401, Conversion, Unfair Competition, and Violation of Penal Code §496. On February 18, 2020, Driven filed a Demurrer to Plaintiffs' First Amended Complaint challenging seven of Plaintiffs' nine causes of action. The hearing on the demurrer, original set for May 1, 2020, has been continued indefinitely due to Court closures. The Company intends to vigorously defend against this action. In February 2020 Irth Communications, LLC filed a complaint in the Superior Court of California, County of Los Angeles, against the Company. The complaint alleges that pursuant to a services agreement the Company issued Irth 500,000 shares of its common stock but the Company breached this agreement because according to the complaint, the Company has refused to authorized its transfer agent to remove the restrictive legend on the Shares. Among other remedies, Irth seeks at least $1,130,000 in compensatory damages, attorneys' fees, and injunctive relief. The Company is reviewing the Complaint and intends to defend itself vigorously. On January 3, 2020, the Company entered into a consulting agreement. As part of this agreement the Company will pay the Consultant $10,000 upon signing of the agreement and an additional $15,000 30 days and 60 days after the signing of the agreement. The Company will also issue 80,000 warrants to purchase the shares of the Company's common stock at an exercise price of $0.50 per share and a term of seven years.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS Transactions involving related parties cannot be presumed to be carried out on an arm's-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm's-length transactions unless such representations can be substantiated. On August 28, 2019, the Company issued a senior convertible note ("Note") to M2 Equity Partners ("Holder"), pursuant to which the Holder agreed to advance the Company $1,000,000. The principal of the note was amended on January 31, 2020 to be $2,637,000 As additional consideration, the Company issued to the Holder a three-year warrant to purchase 4,500,000 shares of the Company's common stock at an exercise price of $0.05. The Company also recognized a derivative liability in connection with the note valued at $567,335 as of December 31, 2019 and $558,160 as of March 31, 2020. M2 is a related party due to the terms of the note giving them a seat on the board of directors of the Company. As of March 31, 2020 there was $2,637,000 outstanding on the note. There was an interest expense of $43,348 related to this note during the three months ended March 31, 2020. There is a total accrued interest of $43,348 as of March 31, 2020. See Note 6. During the year ended December 31, 2019, the Company entered into a loan agreement with the Company's CFO, Brian Hayek. Pursuant to the Loan Agreement, the Company issued Mr. Hayek a Secured Convertible, pursuant to which Mr. Hayek extended a loan to the Company in the amount of $188,743 with an interest rate of 10%. As of March 31, 2020, the amount due on this loan was $184,667. There was an interest expense of $4,604 related to this note during the three months ended March 31, 2020. There is a total accrued interest of $9,756 as of March 31, 2020. On December 31, 2019, the Company entered into a loan agreement with a Director of the Company, Christian Schenk, pursuant to which Mr. Schenk extended a loan to the Company in the amount of $50,000 with an interest rate of 10%. As of March 31, 2020, the amount due on this loan was $50,000. There was an interest expense of $1,247 related to this note during the three months ended March 31, 2020. There is a total accrued interest of $1,260 as of March 31, 2020. On March 25, 2020, the board of directors of the Company appointed Christopher DeSousa as a member of the Board, with such appointment to take effect immediately. In connection with his appointment, the Board approved a grant of an option to purchase 112,500 shares of the Company's common stock at an exercise price of $0.59 per share. These options vest quarterly over one year and expire in three years from the grant date. In addition, Mr. DeSousa shall receive an option to purchase 28,125 shares of Common Stock at the exercise price of $0.59 for each quarter he serves on the Board.

Compensation

Compensation	3 Months Ended
	Mar. 31, 2020
Compensation Related Costs [Abstract]
COMPENSATION	NOTE 11 – COMPENSATION The Company's compensation for the three months March 31, 2020 and 2019 are as follows: Compensation Type Three months ended Three months ended Salary and Wages $ 1,031,200 189,489 Stock Option and Warrant Compensation 327,804 347,694 Total Compensation $ 1,359,004 537,183 The increase in salaries and wages from March 31, 2019 to March 31, 2020 was due to the merges with Ganjarunner and Budee.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS During the second quarter of 2020, the Company issued 1,236,000 warrants to purchase the Company's common stock. These warrants have an exercise price of $0.50 and expire in three or five years. These warrants were issued for services and compensation. During the second quarter of 2020, the Company issued 1,050,000 shares of the Company's common stock. The Company received $525,000 for the sales of this stock. The Company also issued one warrant for each share of common stock sold. These warrants have an exercise price of $0.55 and a expire three years from the grant date. On April 23, 2020, the Company entered into a consulting agreement for investor relation services. As part of this agreement the Company will pay a monthly fee of $8,000. This monthly fee will also increase by 5% every 12 months of service. On April 1, 2020, the Company amended an agreement dated August 27, 2019. As part of this agreement the Company issued warrants to purchase 3,700,000 shares of common stock upon meeting certain milestones related to mergers and acquisitions. These warrants have an exercise price of $0.50 and a term of seven years. During the second quarter of 2020, 13,100,000 warrants were converted to 10,628,611 shares of the Company's common stock through a cashless exercises. On April 9, 2020 our common stock became quoted on the OTCQB under the symbol DRVD.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the rules and regulations of the Securities and Exchange Commission ("SEC" for interim financial information. In the opinion of the Company's management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal, recurring adjustments, considered necessary for a fair presentation of the results for the interim period ended March 31, 2020. Although management believes that the disclosures in these unaudited condensed consolidated financial statements are adequate to make the information presented not misleading, certain information and footnote disclosures normally included in financial statements that have been prepared in accordance U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company's financial statements for the year ended December 31, 2019, which contains the audited financial statements and notes thereto, for the year ended December 31, 2019 included within the Company's Form 10-K filed with the SEC on May 22, 2020. The interim results for the three months ended March 31, 2020 are not necessarily indicative of the results to be expected for the year ended December 31, 2020 or for any future interim periods. The December 31, 2019 Balance Sheet is derived from the Company's audited financial statements but does not include all necessary disclosures for full U.S. GAAP presentation.
Principles of consolidation	Principles of consolidation The consolidated condensed financial statements include the accounts of Driven Deliveries, Inc., and its wholly-owned subsidiaries, Budee, Inc., Ganjarunner, Inc. and Global Wellness, LLC. All significant intercompany balances and transactions have been eliminated in the consolidated condensed financial statements.
Use of estimates	Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates.
Risk factors	Risk factors In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 ("2017 Tax Act"). Corporate taxpayers may carryback net operating losses (NOLs) originating between 2018 and 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act. In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation.
Concentrations	Concentrations The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may have deposits in excess of federally insured limits.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2020 and December 31, 2019, the Company did not have any cash equivalents.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost or net realizable value, on an average cost basis. Inventory is determined to be salable based on demand forecast within a specific time horizon. Inventory in excess of salable amounts is considered obsolete, at which point it is written down to its net realizable value.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The Company does not record an allowance for doubtful accounts.
Goodwill	Goodwill We review goodwill for impairment at least annually or more frequently if events or changes in circumstances would more likely than not reduce the fair value of our single reporting unit below its carrying value. As of March 31, 2020, no impairment of goodwill has been identified. Goodwill Balance, January 1, 2019 $ - Additions 1,271,718 Balance, December 31, 2019 1,271,718 Additions 389,281 Balance, March 31, 2020 $ 1,660,999
Intangible Assets	Intangible Assets The Company's intangible assets include the following at March 31, 2020: Cost Basis Accumulated Net at Estimated Trade Names/Trademarks $ 4,440,962 $ (165,967 ) $ 4,274,995       10 IP/Trade Secrets 3,053,060 (313,686 ) 2,739,374 5 License 1,064,684 (51,193 ) 1,013,491 15 Proprietary Software/Technology 4,189,000 (54,105 ) 4,134,895 7 Non-Compete Agreements 536,009 (116,935 ) 419,074 2 Customer Relations 211,000 (17,479 ) 193,521 7 Total Intangible Assets $ 13,494,715 (719,365 ) $ 12,775,350 The Company's intangible assets include the following at December 31, 2019: Cost Basis Accumulated Net at Estimated Life Trade Names/Trademarks $ 1,918,962 $ (95,324 ) $ 1,823,638       10 IP/Trade Secrets 1,978,060 (195,616 ) 1,782,444 5 License 678,684 (22,463 ) 656,221 15 Proprietary Software/Technology 289,009 (69,742 ) 219,267 7 Customer Relations 152,000 (11,303 ) 140,697 7 Total Intangible Assets $ 5,016,715 $ (394,448 ) $ 4,622,267 There was no impairment recorded to intangible assets as of March 31, 2020. Amortization expense was $341,583 and $280,616 for the three months ended March 31, 2020 and December 31, 2019, respectively. The future amortization expense intangible assets are as follows: 2020 (remainder) $ 1,251,254 2021 2,119,392 2022 1,814,416 2023 1,728,525 2024 1,535,478 2025 and after 4,326,285 Total $ 12,775,350
Cost of sales	Cost of Sales Cost of goods sold consists of: Product costs: Product costs include the purchase price of products sold, which include direct and indirect labor costs, rent, and depreciation expenses, and inbound shipping and handling costs for inventory. Fulfillment costs and other: includes the costs of outbound shipping and handling and other costs related to delivering products to the customer. The Company's cost of sales for March 31, 2020 and 2019 are as follows: Cost of Sales Type Three months Three months Cost of Sales – Product Costs $ 1,111,539 - Cost of Sales – Fulfilment Costs and Other 592,848 - Total $ 1,704,387 -
Advertising	Advertising The Company expenses the cost of advertising and promotions as incurred. Advertising expense was $180,080 and $40,774 for the three months ended March 31, 2020 and 2019, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of ASC 718, "Compensation–Stock Compensation", which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or cancelled during the periods reported. The Company accounts for warrants and options issued to non-employees under ASU 2018-07, Equity – Equity Based Payments to Non-Employees, using the Black-Scholes option-pricing model. The Black–Scholes option valuation model requires the development of assumptions that are inputs into the model. These assumptions are the value of the underlying share, the expected stock volatility, the risk–free interest rate, the expected life of the option, the dividend yield on the underlying stock and are accounted for as they occur. Due to the lack of sufficient trading history, the Company benchmarked their volatility to similar companies in a similar industry over the expected option life and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on its Common stock and does not intend to pay dividends on its Common stock in the foreseeable future. The Company records forfeitures as they occur. The Company stock based compensation expense was $327,804 and $347,694 for the three months ended March 31, 2020 and 2019, respectively.
Fair Value Measurements	Fair Value Measurements ASC 820, "Fair Value Measurements and Disclosure," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels are described below: Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company; Level 2 Inputs – Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; Level 3 Inputs – Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants. The carrying amount of the Company's financial assets and liabilities, such as cash, accounts payable, accounts receivables, and accrued expenses approximate their fair value because of the short maturity of those instruments. Non- recurring fair value items are re-assessed at the end of each reporting period. The assets or liability's fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of financial instruments that are measured at fair value as of March 31, 2020. Carrying Fair Value Measurement Using Value Level 1 Level 2 Level 3 Total Derivative liabilities $ (558,160 ) $ - $ - $ (558,160 ) $ (558,160 ) The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2019. Carrying Fair Value Measurement Using Value Level 1 Level 2 Level 3 Total Derivative liabilities $ (306,762 ) $ - $ - $ (306,762 ) $ (306,762 ) The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2020: Fair Value Measurement Using Level 3 Inputs Total Balance, January 1, 2019 $ - Debt Discount 305,424 Change in fair value of derivative liabilities (1,338 ) Balance, December 31, 2019 306,762 Extinguishment (311,360 ) Debt Discount 528,603 Change in fair value of derivative liabilities 34,155 Balance, March 31, 2020 $ 558,160 The level 3 financial instruments consist of embedded conversion features. The fair value of these embedded conversion features are estimated using a Black Scholes valuation model. The fair value of the derivative features were calculated using a Black-Scholes option model valued with the following assumptions: March 31, 2020 December 31, 2019 Exercise price $ 0.50 $ 0.50 Risk free interest rate 0 .88-1.12 % 1.52-1.81 % Dividend yield 0.00 % 0.00 % Expected volatility 97-119 % 93-109 % Contractual term 0.88-1.19 Years 0.91-1.37 Estimated fair value of stock on grant date $ 0.50 $ 0.50 Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of measurement. Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future. Volatility: The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company's peer group stock price for a period consistent with the warrants' expected term. Expected term: The Company's expected term is based on the remaining contractual maturity of the warrants. Changes in the unobservable input values would likely cause material changes in the fair value of the Company's Level 3 financial instruments. The most sensitive unobserved inputs used in valuing derivative instruments are volatility and estimated fair value of the Company's stock on the grant date of the instruments. Significant changes in either of these inputs could have a material effect on the fair value measurement of the derivative instruments. During the three months ended March 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded a loss of $34,155 and $0 relating to the change in fair value, respectively.
Derivative Liability	Derivative Liability The Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated condensed statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity or to gain or loss on extinguishment of the note if the derivative is attached to a note. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date. The pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time of comparable companies equal to the remaining contractual term of the instrument granted.
Revenue Recognition	Revenue Recognition As of January 1, 2018, the Company adopted ASC 606. The adoption of ASC 606, Revenue From Contracts With Customers, represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company's services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. The Company used the Modified-Retrospective Method when adopting this standard. There was no accounting effect due to the initial adoption. To achieve this core principle, the Company applies the following five steps: 1) Identify the contract with a customer The Company sells retail products directly to customers. In these sales there is no formal contract with the customer. These sales have commercial substance and there are no issues with collectability as the customer pays the cost of the goods at the time of purchase or delivery. 2) Identify the performance obligations in the contract The Company sells its products directly to consumers. In this case these sales represent a performance obligation with the sales and any necessary deliveries of those products. 3) Determine the transaction price The sales that are done directly to the customer have no variable consideration or financing component. The transaction price is the cost that those goods are being sold for plus any additional delivery costs. 4) Allocate the transaction price to performance obligations in the contract For the goods that the Company sells directly to customers, the transaction price is allocated between the cost of the goods and any delivery fees that may be incurred to deliver to the customer. 5) Recognize revenue when or as the Company satisfies a performance obligation For the sales of the Company's own goods the performance obligation is complete once the customer has received their product.
Disaggregation of Revenue	Disaggregation of Revenue The following table depicts the disaggregation of revenue according to revenue type. Revenue Type Revenue for the three months ended March 31, 2020 Revenue for the three months ended March 31, 2019 Delivery Income $ 27,043 15,370 Dispensary Cost Reimbursements (7,528 ) (34,787 ) Delivery Income, net 19,515 (19,417 ) Product Sales 2,175,933 - Total $ 2,195,448 (19,417 ) As part of the Company's former delivery business where the Company partnered with dispensaries to deliver their products, the Company was responsible for reimbursing the partnered dispensaries for the wages of the delivery couriers. Due to this reduction of revenue from the reimbursement of wages for the delivery couriers, the Company is presenting a net negative revenue for the three months ended March 31, 2019 for Dispensary Delivery Income.
Leases	Leases Under Topic 842, operating lease expense is generally recognized evenly over the term of the lease. The Company has operating leases primarily consisting of office space with remaining lease terms of 35 months to 37 months. Current facility leases include our offices in El Segundo California, Oakland California, and Sacramento California. Lease costs were $40,375 and $44,060 for the three months ended March 31, 2020 and 2019. There was no sublease rental income for the three months ended March 31, 2020 and 2019. Leases with an initial term of twelve months or less are not recorded on the balance sheet. For lease agreements entered into or reassessed after the adoption of Topic 842, we combine the lease and non-lease components in determining the lease liabilities and right of use ("ROU") assets. Our lease agreements generally do not provide an implicit borrowing rate, therefore an internal incremental borrowing rate is determined based on information available at lease commencement date for purposes of determining the present value of lease payments. We used the incremental borrowing rate on March 31, 2020 and December 31, 2019 for all leases that commenced prior to that date. In determining this rate, which is used to determine the present value of future lease payments, we estimate the rate of interest we would pay on a collateralized basis, with similar payment terms as the lease and in a similar economic environment. Lease Costs Three Months Ended Three Months Ended Components of total lease costs: Operating lease expense $ 40,375 $ 44,060 Total lease costs $ 40,375 $ 44,060 Lease Positions as of March 31, 2020 ROU lease assets and lease liabilities for our operating leases were recorded in the consolidated condensed balance sheet as follows: March 31, December 31, 2019 Assets Right of use asset $ 657,549 $ 115,859 Total assets $ 657,549 $ 115,859 Liabilities Operating lease liabilities – short term $ 295,639 $ 40,217 Operating lease liabilities – long term 362,532 76,264 Total lease liability $ 658,171 $ 116,481 Lease Terms and Discount Rate Weighted average remaining lease term (in years) – operating lease 3.58 Weighted average discount rate – operating lease 10.91 % Cash Flows Three Months Ended Three Months Ended Cash paid for amounts included in the measurement of lease liabilities: ROU amortization $ 40,375 $ 11,274 Cash paydowns of operating liability $ (40,375 ) $ (7,075 ) Supplemental non-cash amounts of lease liabilities arising from obtaining ROU asset $ (657,549 ) $ (261,969 ) Lease Liability $ 658,171 $ 266,869 The future minimum lease payments under the leases are as follows: 2020 (remainder) $ 217,557 2021 250,543 2022 231,678 2023 39,178 Total future minimum lease payments 738,956 Less: Lease imputed interest 80,785 Total $ 658,171
Excise and Sales Tax	Excise and Sales Tax The State of California and various local governments impose certain excise and state and local taxes on product sales. The Company's policy is to include excise taxes as part of sales and cost of sales. The Company's policy for various state and local sales taxes are to exclude them from revenue and cost of sales.
Basic and Diluted Net Loss per Common Share	Basic and Diluted Net Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding for each period. For diluted earnings per common share, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As of March 31, 2020, common stock equivalents are comprised of 34,578,750 warrants and 7,992,433 options.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350)—Simplifying the Test for Goodwill Impairment. ASU 2017-04 simplifies the accounting for goodwill impairments by eliminating the requirement to compare the implied fair value of goodwill with its carrying amount as part of step two of the goodwill impairment test referenced in Accounting Standards Codification ("ASC") 350, Intangibles - Goodwill and Other ("ASC 350"). As a result, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit's fair value. However, the impairment loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. ASU 2017-04 is effective for annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material impact on the Company's consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement" ("ASU 2018-13"). ASU 2018-13 removes, modifies and adds certain disclosure requirements in Topic 820 "Fair Value Measurement". ASU 2018-13 eliminates certain disclosures related to transfers and the valuations process, modifies disclosures for investments that are valued based on net asset value, clarifies the measurement uncertainty disclosure, and requires additional disclosures for Level 3 fair value measurements. ASU 2018-13 is effective for the Company for annual and interim reporting periods beginning January 1, 2020. The adoption of this standard did not have a material impact on the Company's consolidated financial statements and related disclosures. In December 2019, the FASB issued authoritative guidance intended to simplify the accounting for income taxes (ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes"). This guidance eliminates certain exceptions to the general approach to the income tax accounting model and adds new guidance to reduce the complexity in accounting for income taxes. This guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within those annual periods. The Company is currently evaluating the potential impact of this guidance on its consolidated financial statements. In May, 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to US businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provides a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses and the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements. In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivative and Hedging (Topic 815), which clarifies the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. The guidance clarifies how to account for the transition into and out of the equity method of accounting when considering observable transactions under the measurement alternative. The ASU is effective for annual reporting periods beginning after December 15, 2020, including interim reporting periods within those annual periods, with early adoption permitted. We are currently evaluating the impact of the new guidance on our consolidated financial statements. The FASB issues ASUs to amend the authoritative literature in ASC. There have been several ASUs to date, that amend the original text of ASC. Management believes that those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to us or (iv) are not expected to have a significant impact our financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of goodwill	Goodwill Balance, January 1, 2019 $ - Additions 1,271,718 Balance, December 31, 2019 1,271,718 Additions 389,281 Balance, March 31, 2020 $ 1,660,999
Schedule of intangible assets	Cost Basis Accumulated Net at Estimated Trade Names/Trademarks $ 4,440,962 $ (165,967 ) $ 4,274,995       10 IP/Trade Secrets 3,053,060 (313,686 ) 2,739,374 5 License 1,064,684 (51,193 ) 1,013,491 15 Proprietary Software/Technology 4,189,000 (54,105 ) 4,134,895 7 Non-Compete Agreements 536,009 (116,935 ) 419,074 2 Customer Relations 211,000 (17,479 ) 193,521 7 Total Intangible Assets $ 13,494,715 (719,365 ) $ 12,775,350 Cost Basis Accumulated Net at Estimated Life Trade Names/Trademarks $ 1,918,962 $ (95,324 ) $ 1,823,638       10 IP/Trade Secrets 1,978,060 (195,616 ) 1,782,444 5 License 678,684 (22,463 ) 656,221 15 Proprietary Software/Technology 289,009 (69,742 ) 219,267 7 Customer Relations 152,000 (11,303 ) 140,697 7 Total Intangible Assets $ 5,016,715 $ (394,448 ) $ 4,622,267
Schedule of future amortization expense intangible assets	2020 (remainder) $ 1,251,254 2021 2,119,392 2022 1,814,416 2023 1,728,525 2024 1,535,478 2025 and after 4,326,285 Total $ 12,775,350
Schedule of Cost of Sales	Cost of Sales Type Three months Three months Cost of Sales – Product Costs $ 1,111,539 - Cost of Sales – Fulfilment Costs and Other 592,848 - Total $ 1,704,387 -
Schedule of fair value measurement within fair value hierarchy	Carrying Fair Value Measurement Using Value Level 1 Level 2 Level 3 Total Derivative liabilities $ (558,160 ) $ - $ - $ (558,160 ) $ (558,160 ) Carrying Fair Value Measurement Using Value Level 1 Level 2 Level 3 Total Derivative liabilities $ (306,762 ) $ - $ - $ (306,762 ) $ (306,762 )
Schedule of financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs	Fair Value Measurement Using Level 3 Inputs Total Balance, January 1, 2019 $ - Debt Discount 305,424 Change in fair value of derivative liabilities (1,338 ) Balance, December 31, 2019 306,762 Extinguishment (311,360 ) Debt Discount 528,603 Change in fair value of derivative liabilities 34,155 Balance, March 31, 2020 $ 558,160
Schedule of Black-Scholes option model	March 31, 2020 December 31, 2019 Exercise price $ 0.50 $ 0.50 Risk free interest rate 0 .88-1.12 % 1.52-1.81 % Dividend yield 0.00 % 0.00 % Expected volatility 97-119 % 93-109 % Contractual term 0.88-1.19 Years 0.91-1.37 Estimated fair value of stock on grant date $ 0.50 $ 0.50
Schedule disaggregation of revenue	Revenue Type Revenue for the three months ended March 31, 2020 Revenue for the three months ended March 31, 2019 Delivery Income $ 27,043 15,370 Dispensary Cost Reimbursements (7,528 ) (34,787 ) Delivery Income, net 19,515 (19,417 ) Product Sales 2,175,933 - Total $ 2,195,448 (19,417 )
Schedule lease cost	Three Months Ended Three Months Ended Components of total lease costs: Operating lease expense $ 40,375 $ 44,060 Total lease costs $ 40,375 $ 44,060
Schedule lease positions	March 31, December 31, 2019 Assets Right of use asset $ 657,549 $ 115,859 Total assets $ 657,549 $ 115,859 Liabilities Operating lease liabilities – short term $ 295,639 $ 40,217 Operating lease liabilities – long term 362,532 76,264 Total lease liability $ 658,171 $ 116,481 Weighted average remaining lease term (in years) – operating lease 3.58 Weighted average discount rate – operating lease 10.91 % Three Months Ended Three Months Ended Cash paid for amounts included in the measurement of lease liabilities: ROU amortization $ 40,375 $ 11,274 Cash paydowns of operating liability $ (40,375 ) $ (7,075 ) Supplemental non-cash amounts of lease liabilities arising from obtaining ROU asset $ (657,549 ) $ (261,969 ) Lease Liability $ 658,171 $ 266,869
Schedule future minimum lease payments	2020 (remainder) $ 217,557 2021 250,543 2022 231,678 2023 39,178 Total future minimum lease payments 738,956 Less: Lease imputed interest 80,785 Total $ 658,171

Merger and Asset Purchase Agr_2

Merger and Asset Purchase Agreements (Tables)	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Schedule of purchase price allocation	Purchase Price Purchase Price $ 2,987,254 Total purchase price $ 2,987,254 Allocation of purchase price Tangible Assets/(Liabilities) $ (459,464 ) Trade Names/Trademarks 877,000 IP/Trade Secrets 801,000 License 306,000 Non-Compete Agreements 39,000 Customer Relationships 152,000 Goodwill (incl. trained and assembled workforce) 1,271,718 Total allocation of purchase price $ 2,987,254 Purchase Price Purchase Price $ 2,841,715 Total purchase price $ 2,841,715 Allocation of purchase price Trade Names / Trademarks $ 1,041,962 IP/Trade Secrets 1,177,060 License 372,684 Non-Compete Agreements 250,009 Total allocation of purchase price $ 2,841,715 Purchase Price Cash $ 690,504 Stock 6,603,722 Assumed liabilities 1,658,538 Total purchase price $ 8,952,764 Allocation of purchase price Tangible Assets/(Liabilities) $ 85,483 Trade Names/Trademarks 2,522,000 IP/Trade Secrets 1,075,000 License 386,000 Proprietary Software/Technology 4,189,000 Non-Compete Agreements 247,000 Customer Relationships 59,000 Excess Purcahse Price Over Net Liabilites Acquired 389,281 Total allocation of purchase price $ 8,952,764
Schedule of pro-forma combined results of operations	Three Months Three Months March 31, March 31, Gross Revenue $ 2,877,813 2,503,494 Gross Profit $ 1,173,426 1,512,628 Net loss $ (3,558,294 ) (1,255,634 ) Net loss per share, basic and diluted $ (0.08 ) (0.03 ) Weighted average number of shares outstanding 45,726,329 44,290,295

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	3 Months Ended
	Mar. 31, 2020
Summary of warrant activity	Number Weighted Average Exercise Weighted Average Remaining Contractual Life Warrants Outstanding January 1, 2019 9,131,250 0.19 3.83 Granted 27,658,000 0.44 4.29 Forfeited (7,545,500 ) 0.34 4.48 Outstanding December 31, 2019 29,243,750 $ 0.39 4.10 Granted 5,335,000 0.12 2.92 Outstanding March 31, 2020 34,578,750 $ 0.35 3.70
Summary of stock option activity	Number Weighted Average Exercise Weighted Average Remaining Contractual Life Weighted Average Options Outstanding January 1, 2019 4,854,692 0.04 3.00 0.19 Granted 6,210,022 0.16 5.13 0.24 Forfeited (3,184,781 ) 0.19 3.53 0.19 Outstanding December 31, 2019 7,879,933 $ 0.14 4.74 $ 0.24 Granted 112,500 0.59 2.98 0.40 Outstanding March 31, 2020 7,992,433 $ 0.15 4.47 $ 0.24
Option [Member]
Summary of fair value of each stock warrant granted was estimated using the Black-Scholes valuation model	Exercise price $ 0.59 Expected dividend yield 0 % Risk free interest rate 0.77 % Expected life in years 3 Expected volatility 150 % Estimated fair value of stock on grant date $ 0.50 Exercise price $ 0.10 - $0.50 Expected dividend yield 0 % Risk free interest rate 1.49% - 2.63 % Expected life in years 7 Expected volatility 153% - 157 % Estimated fair value of stock on grant date $ 0.50
Summary of nonvested activity	Nonvested Shares Shares Nonvested at January 1, 2019 3,641,019 Granted 6,210,022 Vested (2,840,194 ) Forfeited (3,184,781 ) Nonvested at December 31, 2019 3,826,066 Granted 112,500 Vested (491730 ) Nonvested at March 31, 2020 3,446,836
Warrant [Member]
Summary of fair value of each stock warrant granted was estimated using the Black-Scholes valuation model	Exercise price $ 0.05 - $0.50 Expected dividend yield 0 % Risk free interest rate 0.43% - 1.71 % Expected life in years 3-7 Expected volatility 133% - 148 % Estimated fair value of stock on grant date $ 0.50 Exercise price $ 0.10 - $0.50 Expected dividend yield 0 % Risk free interest rate 1.42% - 2.66 % Expected life in years 3-7 Expected volatility 134% - 158 % Estimated fair value of stock on grant date $ 0.50
Summary of nonvested activity	Nonvested Warrants Shares Nonvested at January 1, 2019 - Granted 27,658,000 Vested (19,762,500 ) Forfeited (7,545,500 ) Nonvested at December 31, 2019 350,000 Granted 5,335,000 Vested (5,378,750 ) Nonvested at March 31, 2020 306,250

Compensation (Tables)

Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Compensation Related Costs [Abstract]
Schedule of compensation	Compensation Type Three months ended Three months ended Salary and Wages $ 1,031,200 189,489 Stock Option and Warrant Compensation 327,804 347,694 Total Compensation $ 1,359,004 537,183

Organization and Nature of Bu_2

Organization and Nature of Business (Details) - shares	1 Months Ended	3 Months Ended
	Aug. 29, 2018	Mar. 31, 2020
Date of incorporation		Jul. 22, 2013
Driven Nevada [Member]
Aggregate of post-split shares	30,000,000

Going Concern Analysis (Details

Going Concern Analysis (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Going Concern Analysis (Textual)
Net loss	$ (3,576,755)	$ (954,387)
Working capital deficit	$ 9,243,561

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Balance, Beginning	$ 1,271,718
Additions	389,281	1,271,718
Balance, Ending	$ 1,660,999	$ 1,271,718

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	$ 13,494,715	$ 5,016,715
Accumulated Amortization	(719,365)	(394,448)
Total Intangible Assets	12,775,350	4,622,267
Customer Relations [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	211,000	152,000
Accumulated Amortization	(17,479)	(11,303)
Total Intangible Assets	$ 193,521	$ 140,697
Estimated Life	7 years	7 years
License [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	$ 1,064,684	$ 678,684
Accumulated Amortization	(51,193)	(22,463)
Total Intangible Assets	$ 1,013,491	$ 656,221
Estimated Life	15 years	15 years
Proprietary Software/Technology [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	$ 4,189,000	$ 289,009
Accumulated Amortization	(54,105)	(69,742)
Total Intangible Assets	$ 4,134,895	$ 219,267
Estimated Life	7 years	7 years
Trade Names / Trademarks [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	$ 4,440,962	$ 1,918,962
Accumulated Amortization	(165,967)	(95,324)
Total Intangible Assets	$ 4,274,995	$ 1,823,638
Estimated Life	10 years	10 years
IP/Trade Secrets [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	$ 3,053,060	$ 1,978,060
Accumulated Amortization	(313,686)	(195,616)
Total Intangible Assets	$ 2,739,374	$ 1,782,444
Estimated Life	5 years	5 years
Non-Compete Agreements [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost Basis	$ 536,009
Accumulated Amortization	(116,935)
Total Intangible Assets	$ 419,074
Estimated Life	2 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details 2)	Mar. 31, 2020USD ($)
Accounting Policies [Abstract]
2020 (remainder)	$ 1,251,254
2021	2,119,392
2022	1,814,416
2023	1,728,525
2024	1,535,478
2025 and after	4,326,285
Total	$ 12,775,350

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details 3) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accounting Policies [Abstract]
Cost of Sales – Product Costs	$ 1,111,539
Cost of Sales – Fulfilment Costs and Other	592,848
Total	$ 1,704,387

Summary of Significant Accoun_8

Summary of Significant Accounting Policies (Details 4) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]
Derivative Liability	$ 558,160	$ 306,762	$ 306,762
Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liability
Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liability
Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liability	(241,298)		(306,762)
Carrying Value [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative Liability	$ (241,298)		$ (306,762)

Summary of Significant Accoun_9

Summary of Significant Accounting Policies (Details 5) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accounting Policies [Abstract]
Balance at beginning	$ 306,762
Extinguishment	(311,360)
Debt discount	528,603	305,424
Change in fair value of derivative liabilities	34,155	(1,338)
Balance at ending	$ 558,160	$ 306,762

Summary of Significant Accou_10

Summary of Significant Accounting Policies (Details 6) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Exercise price	$ 0.50	$ 0.50
Dividend yield	0.00%	0.00%
Estimated fair value of stock on grant date	$ 0.50	$ 0.50
Minimum [Member]
Risk free interest rate	0.88%	1.52%
Expected volatility	97.00%	93.00%
Contractual term	10 months 17 days	10 months 28 days
Maximum [Member]
Risk free interest rate	1.12%	1.81%
Expected volatility	119.00%	109.00%
Contractual term	1 year 2 months 8 days	1 year 4 months 13 days

Summary of Significant Accou_11

Summary of Significant Accounting Policies (Details 7) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues	$ 2,195,448	$ (19,417)
Delivery Income [Member]
Revenues	27,043	15,370
Dispensary Cost Reimbursements [Member]
Revenues	(7,528)	(34,787)
Delivery Income, net [Member]
Revenues	19,515	(19,417)
Product Sales [Member]
Revenues	$ 2,175,933

Summary of Significant Accou_12

Summary of Significant Accounting Policies (Details 8) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Components of total lease costs:
Operating lease expense	$ 40,375	$ 44,060
Total lease costs	$ 40,375	$ 44,060

Summary of Significant Accou_13

Summary of Significant Accounting Policies (Details 9) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Assets
Right of use asset	$ 657,549		$ 115,859
Total assets	657,549		115,859
Liabilities
Operating lease liabilities - short term	295,639		40,217
Operating lease liabilities - long term	362,532		76,264
Total lease liability	$ 658,171		$ 116,481
Lease Terms and Discount Rate
Weighted average remaining lease term (in years) - operating lease	3 years 6 months 29 days
Weighted average discount rate - operating lease	10.91%
Cash paid for amounts included in the measurement of lease liabilities:
ROU amortization	$ 40,375	$ 11,274
Cash paydowns of operating liability	(40,375)	(7,075)
Supplemental non-cash amounts of lease liabilities arising from obtaining ROU asset	(657,549)	(261,969)
Supplemental non-cash amounts of lease liabilities arising from obtaining lease Liability	$ 658,171	$ 266,869

Summary of Significant Accou_14

Summary of Significant Accounting Policies (Details 10)	Mar. 31, 2020USD ($)
Accounting Policies [Abstract]
2020 (remainder)	$ 217,557
2021	250,543
2022	231,678
2023	39,178
Total future minimum lease payments	738,956
Less: Lease imputed interest	80,785
Total	$ 658,171

Summary of Significant Accou_15

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Summary of Significant Accounting Policies (Textual)
Amortization expense	$ 341,583	$ 280,616
Compensation expense	327,804	34,769
warrants to fair value and recorded a loss	$ 34,155	$ 0
Operating lease expense, Description	The Company has operating leases primarily consisting of office space with remaining lease terms of 35 months to 37 months. Current facility leases include our offices in El Segundo California, Oakland California, and Sacramento California. Lease costs were $40,375 and $44,060 for the three months ended March 31, 2020 and 2019.
Warrants options	34,578,750	7,992,433
Advertising expense	$ 180,080	$ 40,774
Operating lease liability	$ 658,171		$ 116,481
Ownership percentage	0.51%
Risk factors, description	In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (“2017 Tax Act”). Corporate taxpayers may carryback net operating losses (NOLs) originating between 2018 and 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act.
Taxable income percentage	25.00%
Cost recovery year	15 years
Bonue depreciation	100.00%

Merger And Assets Purchase Agre

Merger And Assets Purchase Agreement (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Purchase Price
Total purchase price	$ 1,660,999	$ 1,271,718
Allocation of purchase price
Total allocation of purchase price	1,660,999	$ 1,271,718
Ganjarunner [Member]
Purchase Price
Purchase Price	2,987,254
Total purchase price	2,987,254
Allocation of purchase price
Tangible Assets/ (Liabilities)	(459,464)
Trade Names / Trademarks	877,000
IP/Trade Secrets	801,000
License	306,000
Non-Compete Agreements	39,000
Customer Relationships	152,000
Goodwill (incl. trained and assembled workforce)	1,271,718
Total allocation of purchase price	2,987,254
Mountain High Recreation, Inc (Member)
Purchase Price
Purchase Price	2,841,715
Total purchase price	2,841,715
Allocation of purchase price
Trade Names / Trademarks	1,041,962
IP/Trade Secrets	1,177,060
License	372,684
Non-Compete Agreements	250,009
Total allocation of purchase price	2,841,715
Budee Merger (Member)
Purchase Price
Purchase Price	690,504
Stock	6,603,722
Assumed liabilities	1,658,538
Total purchase price	8,952,764
Allocation of purchase price
Tangible Assets/ (Liabilities)	85,483
Trade Names / Trademarks	2,522,000
IP/Trade Secrets	1,075,000
License	386,000
Proprietary Software/Technology	4,189,000
Non-Compete Agreements	247,000
Customer Relationships	59,000
Excess Purcahse Price Over Net Liabilites Acquired	389,281
Total allocation of purchase price	$ 8,952,764

Merger and Assets Purchase Ag_2

Merger and Assets Purchase Agreement (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Business Combinations [Abstract]
Gross Revenue	$ 2,877,813	$ 2,503,494
Gross Profit	1,173,426	1,512,628
Net loss	$ (3,558,294)	$ (1,255,634)
Net loss per share, basic and diluted	$ (0.08)	$ (0.03)
Weighted average number of shares outstanding	45,726,329	44,290,295

Merger and Assets Purchase Ag_3

Merger and Assets Purchase Agreement (Details Textual) - USD ($)	Oct. 04, 2019	Feb. 27, 2020	Jul. 10, 2019	Jun. 21, 2019	Mar. 31, 2020	Dec. 31, 2019
Merger Agreement (Textual)
Merger agreement, description		The Company, Budee Acquisition, Inc., a Nevada corporation and Budee, Inc. ("Budee"), a California corporation, pursuant to which the Company acquired Budee (the "Budee Acquisition"). On the Effective Date, all then-issued and outstanding shares of Budee were canceled and Budee issued 1,000,000 new shares of its common stock, representing 100% of the now issued and outstanding shares of Budee, to the Company. As a result, Budee became a wholly-owned subsidiary of the Company. As consideration, the Company agreed to: i) cash payments to Budee of $725,000 in three payments of $225,000, $200,000 and $300,000, due April 15, 2020, July 15, 2020 and October 15, 2020, respectively, and ii) issue to Budee 13,333,333 shares of the Company's common stock (the "Consideration Shares"). 1,333,333 of the 13,333,333 shares will not be issued until the completion of a lawsuit.	The Company agreed to pay to MH the following: $200,000 at Closing, $150,000 on or before December 20, 2019, $150,000 on or before March 31, 2020, $250,000 at the end of the twelfth (12th) month (on a rolling basis) following the Closing Date and $250,000 at the end of the twenty-fourth (24th) month (on a rolling basis) following the Closing Date. In addition, at Closing, the Company issued to MH 1,000,000 shares of its common stock. At the end of the twelfth month (on a rolling basis) from the Closing Date, the Company agreed to issue to MH warrants to purchase 2,000,000 shares of the Company's Common Stock with an exercise price equal to the per share purchase price paid by investors of the Company's then most recent private placement and exercisable for a period of three (3) years from the date of issuance (the "2020 Warrants"). At the end of the twenty-fourth month (on a rolling basis) from the Closing Date, the Company shall issue to MH warrants to purchase 2,000,000 shares of the Company's Common Stock with an exercise price equal to the per share purchase price paid by investors of the Company's then most recent private placement price, exercisable for a period of three (3) years from the date of issuance (the "2021 Warrants").	The Merger closed on June 24, 2019 (the “Closing Date”). Pursuant to the Merger Agreement, the Company agreed to pay to GR/GW $1,000,000, $150,000 of which has already been paid to GR/GW with $300,000 to be paid in two equal tranches of $150,000 whereby each tranche is subject to GRA’s achievement of certain milestones. (i) $350,000 at the earlier to occur of the 6-month anniversary of the Closing Date or upon the Company raising additional funding of at least $2,000,000 and (ii) $300,000 at the end of the 24-month anniversary of the Closing Date. In addition, as further consideration, the Company issued to GR/GW’s founders 1,000,000 shares of the Company’s common stock on the Closing Date and shall make two additional issuances of 2,000,000 shares of common stock on the 12-month and 24-month anniversaries of the Closing Date, with each respective issuance contingent upon GRA’s achievement of certain milestones as set forth in the Merger Agreement.
Shares of common stock issued	5,000,000
Ganjarunner [Member]
Merger Agreement (Textual)
Warrants to purchase	5,000,000
Exercise price	$ 0.50
Amount payable on acquisition					$ 583,886	$ 583,886
Mountain High Recreation, Inc (Member)
Merger Agreement (Textual)
Warrants to purchase	5,000,000		2,000,000
Exercise price	$ 0.50
Amount payable on acquisition					708,347	708,347
Budee Merger (Member)
Merger Agreement (Textual)
Amount payable on acquisition					$ 1,294,226	$ 0

Joint Venture (Detail)

Joint Venture (Detail)	1 Months Ended
	Sep. 30, 2019
Ganjarunner [Member]
Joint Venture (Textual)
Joint venture, description	GB is a separate and independent entity from either party with its own management team and Board of Directors and is owned 51% by the Company and 49% by Budee. The term of GB will continue until such GanjaBudee Merger is effective or any definitive agreement for such GanjaBudee Merger is terminated but in any case will not be for a period of more than sixty months, subject to a mutual extension agreed to by the parties.
Budee Merger (Member)
Joint Venture (Textual)
Joint venture, description	The Company and Budee agreed to share certain expenses between the Company and Budee, Inc. The Company is also allowed to charge an additional 10% fee on any of these charged back expenses. The Company charged back expenses to Budee totaling $96,610 during the three months ended March 31, 2020. In addition, pursuant to the JV Agreement the Company agreed to pay certain obligations of Budee Inc. of $250,000. As of March 31, 2020, the Company has not paid this amount. As part of this joint venture the Company recognized a loss attributable to non-controlling interest of $656,189 for the three months ended March 31, 2020, which was eliminated upon the merger with Budee.

Notes Payable (Details)

Notes Payable (Details)	1 Months Ended	3 Months Ended	12 Months Ended
	Aug. 28, 2019	Mar. 31, 2020	Dec. 31, 2019
Notes Payable (Textual)
Convertible note, description		The Company recognized a $810,518 loss on the extinguishment of debt for the old note. The loss is due to $1,497,000 from the extinguishment of the note, $311,360 from the extinguishment of the derivative offset by $499,505 from the extinguishment of the debt discount and $2,119,373 from the recognition of the new note. The Company recognized a debt discount on the new note of $528,603 at the date of issuance. The Company recognized $83,464 in amortization on the debt discount during the three months ended March 31, 2020, leaving a remaining debt discount of $445,139 at March 31, 2020.
Ownership of stock, percentage		0.51%
Mr.Brian Hayek [Member]
Notes Payable (Textual)
Description of loan agreement			The Company entered into a loan agreement with the Company's CFO, Brian Hayek. Pursuant to the Loan Agreement, the Company issued Mr. Hayek a Secured Convertible Note in the principal amount of $188,743 with an interest rate of 10%. As of March 31, 2020, the amount due on this loan was $184,667. The note is convertible into shares of the Company's equity securities at a price of $0.50 per share or preferred stock designated by the parties in an amount equivalent to a value of $0.50 per share on an as converted basis. The obligation of the Note is an obligation of the Company other than obligations specifically designated otherwise by the Company. In addition, the Company issued Mr. Hayek warrants to purchase 500,000 shares of the Company's common stock at an exercise price of $0.50 per share which warrants terminate five years after their issuance. As part of this loan the Company recognized the intrinsic value of a beneficial conversion feature resulting in a debt discount of $102,111 as of the date of issuance. The Company had a remaining debt discount of $101,831 at December 31, 2019. The Company recognized $25,458 in amortization on the debt discount during the three months ended March 31, 2020, leaving a remaining debt discount of $76,373 at March 31, 2020.
Christian Schenk [Member]
Notes Payable (Textual)
Description of loan agreement			The Company entered into a loan agreement with a Director of the Company, Christian Schenk, pursuant to which Mr. Schenk extended a loan to the Company in the amount of $50,000 with an interest rate of 10%. In connection with this loan, the Company issued Mr. Schenk a secured convertible note. The note is convertible into equity of the Company at a price of $0.50 per share of common stock. The note was funded with the proceeds from the forgivingness of $30,000 in accounts payable to Truck That, LLC and a check from Truck That, LLC in the amount of $20,000 (see Note 9). In addition, the Company issued Mr. Schenk warrants to purchase 150,000 shares of the Company's common stock at an exercise price of $0.50 per share which warrants terminate five years after their issuance. As part of this loan the Company recognized the intrinsic value of a beneficial conversion feature resulting in a debt discount of $28,585 as of the date of issuance. The Company had a remaining debt discount of $28,507 at December 31, 2019.The Company recognized $7,127 in amortization on the debt discount during the three months ended March 31, 2020, leaving a remaining debt discount of $21,380 at March 31, 2020.
Holder [Member]
Notes Payable (Textual)
Convertible note, description	The Company issued a senior convertible note ("Note") to M2 Equity Partners ("Holder"), pursuant to which the Holder agreed to advance the Company $1,000,000 in three equal installments, with the final installment advanced on October 30, 2019. The Note matures on August 28, 2020 and is the senior obligation of the Company. The Note's principal balance of $1,000,000 bears interest at a rate of 10% per annum and interest payments are payable on a monthly basis. The funds from this loan were distributed in three parts with $333,333 being issued on August 30, 2019, September 30, 2019 and October 30, 2019. An additional $497,000 was received in excess of the original note as of December 31, 2019. These amounts were subject to the same terms as the original note. An additional $1,140,000 was received in excess of the original note during the first quarter of 2020. The principal of the note was amended on January 31, 2020 to be $2,637,000. This amendment also changed the maturity date of the note to February 14, 2021. As of March 31, 2020, the Company had received $2,637,000 in funds from the note.	The Company had received $2,637,000 in funds from the note. Pursuant to the Note, the Holder has the right to convert all or part of the Note to shares of common stock of the Company at a price equivalent to a value of $0.50 per share of common stock on an as-converted basis. As additional consideration for entering into the exchange, the Company issued to the Holder a three-year warrant to purchase 4,500,000 shares of the Company's common stock at an exercise price of $0.05. The Company also recognized a derivative liability in connection with the note valued at $567,335 as of December 31, 2019 and $558,160 as of March 31, 2020.
Matthew Atkinson [Member]
Notes Payable (Textual)
Ownership of stock, percentage		5.98%

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Exercise price	$ 0.50	$ 0.50
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Risk free interest rate	0.88%	1.52%
Expected life in years	10 months 17 days	10 months 28 days
Maximum [Member]
Risk free interest rate	1.12%	1.81%
Expected life in years	1 year 2 months 8 days	1 year 4 months 13 days
Warrant [Member]
Expected dividend yield	0.00%	0.00%
Estimated fair value of stock on grant date	$ 0.50	$ 0.50
Warrant [Member] | Minimum [Member]
Exercise price	$ 0.05	$ 0.10
Risk free interest rate	0.43%	1.42%
Expected life in years	3 years	3 years
Expected volatility	133.00%	134.00%
Warrant [Member] | Maximum [Member]
Exercise price	$ 0.50	$ 0.50
Risk free interest rate	1.71%	2.66%
Expected life in years	7 years	7 years
Expected volatility	148.00%	158.00%

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Stockholder Equity [Abstract]
Number, Beginning	29,243,750	9,131,250
Number, Granted	5,335,000	27,658,000
Number, Forfeited		(7,545,500)
Number, Ending	34,578,750	29,243,750
Weighted Average Exercise Price, Beginning	$ 0.39	$ 0.19
Weighted Average Exercise Price, Granted	0.12	0.44
Weighted Average Exercise Price, Forfeited		0.34
Weighted Average Exercise Price, Ending	$ 0.35	$ 0.39
Weighted Average Remaining Contractual Life, Beginning	4 years 1 month 6 days	3 years 9 months 29 days
Weighted Average Remaining Contractual Life, Granted	2 years 11 months 1 day	4 years 3 months 15 days
Weighted Average Remaining Contractual Life, Forfeited		4 years 5 months 23 days
Weighted Average Remaining Contractual Life, Ending	3 years 8 months 12 days	4 years 1 month 6 days

Stockholders' Deficit (Detail_2

Stockholders' Deficit (Details 2) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Stockholder Equity [Abstract]
Nonvested Shares, Beginning balance	350,000
Nonvested Shares, Granted	5,335,000	27,658,000
Nonvested Shares, Vested	(5,378,750)	(19,762,500)
Nonvested Shares, Forfeited		(7,545,500)
Nonvested Shares, Ending balance	306,250	350,000

Stockholders' Deficit (Detail_3

Stockholders' Deficit (Details 3) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Exercise price	$ 0.50	$ 0.50
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Risk free interest rate	0.88%	1.52%
Expected life in years	10 months 17 days	10 months 28 days
Maximum [Member]
Risk free interest rate	1.12%	1.81%
Expected life in years	1 year 2 months 8 days	1 year 4 months 13 days
Options [Member]
Exercise price	$ 0.59
Expected dividend yield	0.00%	0.00%
Risk free interest rate	0.77%
Expected life in years	3 years	7 years
Expected volatility	150.00%
Estimated fair value of stock on grant date	$ 0.50	$ 0.50
Options [Member] | Minimum [Member]
Exercise price		$ 0.10
Risk free interest rate		1.49%
Expected volatility		153.00%
Options [Member] | Maximum [Member]
Exercise price		$ 0.50
Risk free interest rate		2.63%
Expected volatility		157.00%

Stockholders' Deficit (Detail_4

Stockholders' Deficit (Details 4) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Stockholder Equity [Abstract]
Number, Beginning	7,879,933	4,854,692
Number, Granted	112,500	6,210,022
Number, Forfeited		(3,184,781)
Number, Ending	7,992,433	7,879,933
Weighted Average Exercise Price, Beginning	$ 0.14	$ 0.04
Weighted Average Exercise Price, Granted	0.59	0.16
Weighted Average Exercise Price, Forfeited		0.19
Weighted Average Exercise Price, Ending	$ 0.15	$ 0.14
Weighted Average Remaining Contractual Life, Beginning	4 years 8 months 26 days	3 years
Weighted Average Remaining Contractual Life, Granted	2 years 11 months 23 days	5 years 1 month 16 days
Weighted Average Remaining Contractual Life, Forfeited		3 years 6 months 10 days
Weighted Average Remaining Contractual Life, Ending	4 years 5 months 20 days	4 years 8 months 26 days
Weighted Average Grant Date Fair Value, Beginning	$ 0.24	$ 0.19
Weighted Average Grant Date Fair Value, Granted	0.40	0.24
Weighted Average Grant Date Fair Value, Forfeited		0.19
Weighted Average Grant Date Fair Value, Ending	$ 0.24	$ 0.24

Stockholders' Deficit (Detail_5

Stockholders' Deficit (Details 5) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Stockholder Equity [Abstract]
Nonvested Shares, Beginning balance	3,826,066	3,641,019
Nonvested Shares, Granted	112,500	6,210,022
Nonvested Shares, Vested	(491,730)	(2,840,194)
Nonvested Shares, Forfeited		(3,184,781)
Nonvested Shares, Ending balance	3,446,836	3,826,066

Stockholders' Deficit (Detail_6

Stockholders' Deficit (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Stockholders' Deficit (Textual)
Common stock, shares authorized	200,000,000		200,000,000
Common stock, par value	$ 0.0001		$ 0.0001
Number of common stock issued shares	674,000
Issuance of common stock value	$ 206,265	$ 103,632
Preferred stock, par value	$ 0.0001		$ 0.0001
Preferred stock, shares authorized	15,000,000		15,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Warrants outstanding	34,578,570		29,243,750
Options outstanding	7,992,433		7,879,933	4,854,692
Description of issued warrants to purchase	The Company issued warrants to purchase an aggregate of 5,335,000 shares of common stock of the Company at an exercise price of $0.05 or $0.50 per share. The warrants may be exercised on a cashless basis and have a term of three, five, or seven years. 375,000 warrants were issued for consulting services, 4,500,000 warrants in connection with notes issued, and 460,000 warrants in connection with stock sold.
Budee [Member]
Stockholders' Deficit (Textual)
Number of common stock issued shares	12,000,000
Warrant [Member]
Stockholders' Deficit (Textual)
Purchase of common stock shares	5,335,000
Stock compensation expense	$ 206,265	103,632
Warrant [Member] | Minimum [Member]
Stockholders' Deficit (Textual)
Exercise price	$ 0.05
Warrant [Member] | Maximum [Member]
Stockholders' Deficit (Textual)
Exercise price	$ 0.50
Options [Member]
Stockholders' Deficit (Textual)
Purchase of common stock shares	112,500
Exercise price	$ 0.59
Stock compensation expense	$ 121,538	$ 245,344

Commitments and Contingencies (

Commitments and Contingencies (Details) - $ / shares	Jan. 03, 2020	Mar. 31, 2020
Purchase shares		674,000
Service Agreement [Member]
Agreement, description		In February 2020 Irth Communications, LLC filed a complaint in the Superior Court of California, County of Los Angeles, against the Company. The complaint alleges that pursuant to a services agreement the Company issued Irth 500,000 shares of its common stock but the Company breached this agreement because according to the complaint, the Company has refused to authorized its transfer agent to remove the restrictive legend on the Shares. Among other remedies, Irth seeks at least $1,130,000 in compensatory damages, attorneys’ fees, and injunctive relief. The Company is reviewing the Complaint and intends to defend itself vigorously.
Consulting Agreement [Member]
Purchase shares	80,000
Exercise price	$ 0.50
Agreement, description	The Company entered into a consulting agreement. As part of this agreement the Company will pay the Consultant $10,000 upon signing of the agreement and an additional $15,000 30 days and 60 day after the signing of the agreement. The Company will also issue 80,000 warrants to purchase the shares of the Company’s common stock an exercise price of $0.50 per share and a term of seven years.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	1 Months Ended		3 Months Ended
	Mar. 25, 2020	Jan. 31, 2020	Mar. 31, 2020	Dec. 31, 2019	Aug. 28, 2019	Mar. 31, 2019	Dec. 31, 2018
Related Party Transactions (Textual)
Loan amount due			$ 2,637,000
Recognized derivative liability			558,160	$ 306,762		$ 306,762
Interest expenses			43,348
Accrued interest			43,348
Convertible Debt [Member]
Related Party Transactions (Textual)
Loan amount due		$ 2,637,000
Exercise price		$ 0.05
Convertible note advance					$ 1,000,000
Warrant to purchase shares of common stock		4,500,000
Recognized derivative liability		$ 567,335	567,335
Christopher DeSousa [Member]
Related Party Transactions (Textual)
Options to purchase shares of common stock	112,500
Exercise price	$ 0.59
Service paid per month	$ 28,125
Loan agreement [Member] | Mr.Brian Hayek [Member]
Related Party Transactions (Textual)
Loan amount due				$ 188,743
Loan from related party			184,667
Debt interest percentage rate				10.00%
Interest expenses			4,604
Accrued interest			9,756
Loan agreement [Member] | Christian Schenk [Member]
Related Party Transactions (Textual)
Loan amount due				$ 50,000
Loan from related party			50,000
Debt interest percentage rate				10.00%
Interest expenses			1,247
Accrued interest			$ 1,260

Compensation (Details)

Compensation (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Compensation Type
Salary and Wages	$ 1,031,200	$ 189,489
Stock Option and Warrant Compensation	327,804	347,694
Total Compensation	$ 1,359,004	$ 537,183

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Apr. 02, 2020	Apr. 23, 2020	Mar. 31, 2020	Jun. 30, 2020
Subsequent Events (Textual)
Taxable income percentage			25.00%
Cost recovery year			15 years
Bonue depreciation			100.00%
Subsequent Event [Member]
Subsequent Events (Textual)
Common stock for sales of stock				$ 525,000
Warrants have an exercise price				$ 0.55
Warrant to purchase shares of common stock				1,050,000
Warrant term				3 years
Description of amendment	The Company amended an agreement dated August 27, 2019. As part of this agreement the Company issued warrants to purchase 3,700,000 shares of common stock upon meeting certain milestones related to mergers and acquisitions. These warrants have an exercise price of $0.50 and a term of seven years.
Converted into common shares				10,628,611
Shares issued				13,100,000
Subsequent Event [Member] | Warrant [Member]
Subsequent Events (Textual)
Warrants have an exercise price				$ 0.50
Warrant to purchase shares of common stock				1,236,000
Subsequent Event [Member] | Consulting Agreement [Member]
Subsequent Events (Textual)
Description of consulting agreement		As part of this agreement the Company will pay a monthly fee of $8,000. This monthly fee will also increase by 5% every 12 months of service.